{"prompt":"\n    \"Title: Vorinostat Description: Women in the vorinostat group were scheduled to receive 6 doses of oral vorinostat at 300 mg twice daily (bid), with the last dose administered by study personnel approximately 2 hours before the scheduled breast surgery (or biopsy).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Vorinostat\",\n        \"dosage\": \"300 mg\",\n        \"frequency\": \"twice daily (bid)\",\n        \"start\": \"start of treatment\",\n        \"end\": \"2 hours before scheduled breast surgery (or biopsy)\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tissue Only Description: Women who declined vorinostat but agreed to donate tissues for biomarker assessment, signed a separate informed consent and were enrolled as controls.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\u201cmedication\": \u201cN\/A\", \"dosage\": \"N\/A\", \"frequency\": \"N\/A\", \"start\": \"N\/A\", \"end\": \"N\/A\"}]###"}
{"prompt":"\n    \"Title: Arm I Description: Patients receive oral vorinostat twice daily on days -3 to 0. Approximately 2 hours after the final dose of vorinostat, patients undergo conventional surgery of the tumor on day 0. After completion of study treatment, patients are followed for 30 days.\n\nvorinostat: Given orally, conventional surgery to follow.\n\nconventional surgery: Undergo conventional surgery\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"vorinostat\",\n        \"dosage\": \"twice daily\",\n        \"frequency\": \"daily\",\n        \"start\": \"-3 days\",\n        \"end\": \"0 days\"\n    },\n    {\n        \"medication\": \"conventional surgery\",\n        \"dosage\": \"NA\",\n        \"frequency\": \"NA\",\n        \"start\": \"0 days\",\n        \"end\": \"NA\"\n    }\n]###"}
{"prompt":"\n    \"Title: Ruboxistaurin Description: 32 mg given once daily as oral tablet for 2 years.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ruboxistaurin\",\n        \"dosage\": \"32 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"now\",\n        \"end\": \"2 years\"\n    }\n]###"}
{"prompt":"\n    \"Title: Pancreatic Adenocarcinoma Patients Description: Pancreatic Adenocarcinoma Patients treated with chemotherapy regimen and radiation (and or surgery). Patients will be given one cycle of continuous infusion 5-FU (175 mg\/m^2\/day for 38 days), weekly cisplatin 30 mg\/m^2 over 1 hour, and IFN-alpha-2b (3 million units given subcutaneously on days 1, 3, and 5 of each week for 5\u00bd weeks) with radiation therapy (5040 cGy total, in 28 fractions, at 180 cGy\/fraction daily, Monday -Friday, for 5\u00bd weeks) followed by two cycles of bolus 5-FU alone (500 mg\/m^2 weekly * 6, followed by 2 weeks of rest).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"5-FU\",\n        \"dosage\": \"175 mg\/m^2\/day\",\n        \"frequency\": \"continuous infusion\",\n        \"start\": \"start of cycle\",\n        \"end\": \"end of cycle\"\n    },\n    {\n        \"medication\": \"Cisplatin\",\n        \"dosage\": \"30 mg\/m^2\",\n        \"frequency\": \"weekly\",\n        \"start\": \"start of cycle\",\n        \"end\": \"end of cycle\"\n    },\n    {\n        \"medication\": \"IFN-alpha-2b\",\n        \"dosage\": \"3 million units\",\n        \"frequency\": \"subcutaneously on days 1, 3, and 5 of each week\",\n        \"start\": \"start of cycle\",\n        \"end\": \"end of cycle\"\n    },\n    {\n        \"medication\": \"Radiation Therapy\",\n        \"dosage\": \"5040 cGy total, in 28 fractions, at 180 cGy\/fraction daily\",\n        \"frequency\": \"Monday -Friday\",\n        \"start\": \"start of cycle\",\n        \"end\": \"end of cycle\"\n    },\n    {\n        \"medication\": \"5-FU\",\n        \"dosage\": \"500 mg\/m^2 weekly\",\n        \"frequency\": \"bolus\",\n        \"start\": \"start of cycle\",\n        \"end\": \"end of cycle\"\n    }\n]###"}
{"prompt":"\n    \"Title: Early Treated Description: Humatrope administered according to investigator's clinical practice and guided by the approved package insert.\n\nHumatrope administered in B9R-US-GDFG (NCT00406926).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Humatrope\",\n        \"dosage\": \"According to investigator's clinical practice and guided by the approved package insert.\",\n        \"frequency\": \"Not specified\",\n        \"start\": \"Not specified\",\n        \"end\": \"Not specified\"\n    }\n]###"}
{"prompt":"\n    \"Title: Early Untreated Description: Humatrope administered according to investigator's clinical practice and guided by the approved package insert.\n\nControl: Humatrope was not administered in B9R-US-GDFG (NCT00406926).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"\n[\n    {\n        \"medication\": \"Humatrope\",\n        \"dosage\": \"According to investigator's clinical practice\",\n        \"frequency\": \"Guided by the approved package insert\",\n        \"start\": \"Early\",\n        \"end\": \"Untreated\"\n    },\n    {\n        \"medication\": \"Humatrope\",\n        \"dosage\": \u201cN\/A\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\u201d\n    }\n]###"}
{"prompt":"\n    \"Title: Group A: Ibuprofen Alone Description: Time 0 Ibuprofen (10mg\/kg)given. Temperature in \u00b0C measured hourly for 6 hours.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Ibuprofen\",\n        \"dosage\": \"10mg\/kg\",\n        \"frequency\": \"once\",\n        \"start\": \"Time 0\",\n        \"end\": \"6 hours\"\n }]###"}
{"prompt":"\n    \"Title: Group C: Ibuprofen Then Acetaminophen Description: Time 0 child is given Ibuprofen (10mg\/kg) and at time 3 hours is given (15 mg\/kg. Temperature in \u00b0C measured hourly for 6 hours.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ibuprofen\",\n        \"dosage\": \"10mg\/kg\",\n        \"frequency\": \"once\",\n        \"start\": \"time 0\",\n        \"end\": \"time 0\"\n    },\n    {\n        \"medication\": \"Acetaminophen\",\n        \"dosage\": \"15mg\/kg\",\n        \"frequency\": \"once\",\n        \"start\": \"time 3 hours\",\n        \"end\": \"time 3 hours\"\n    }\n]###"}
{"prompt":"\n    \"Title: Zoledronic Acid Description: 3.0-4.0 mg by IV (in the vein), once a month for 6 months\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Zoledronic Acid\",\n        \"dosage\": \"3.0-4.0 mg\",\n        \"frequency\": \"once a month\",\n        \"start\": \"now\",\n        \"end\": \"6 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group II: Golimumab 50 mg Description: Golimumab 50 mg SC injections every 4 wks from Wk 0 thru 5 yrs (unless early escape at Wk 16); golimumab - If early escape, 100 mg SC every 4 wks beginning Wk 16 up to 5 yrs; golimumab - Dr's discretion after unblinding, dose adjust from 50 to 100 mg.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Golimumab\",\n            \"dosage\": \"50 mg\",\n            \"frequency\": \"every 4 wks\",\n            \"start\": \"Wk 0\",\n            \"end\": \"5 yrs\"\n        },\n        {\n            \"medication\": \"Golimumab\",\n            \"dosage\": \"100 mg\",\n            \"frequency\": \"every 4 wks\",\n            \"start\": \"Wk 16\",\n            \"end\": \"5 yrs\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Group III: Golimumab 100 mg Description: Golimumab 100 mg SC injections every 4 wks from Wk 0 up to 5 yrs.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"100 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"5 years\"\n    }\n]###"}
{"prompt":"\n    \"Title: PROCRIT 40,000 IU QW Description: Epoetin alpha (PROCRIT) 40,000 IU every week (QW) for 18 weeks (intravenous or subcutaneous)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"PROCRIT\",\n        \"dosage\": \"40,000 IU\",\n        \"frequency\": \"QW\",\n        \"start\": \"now\",\n        \"end\": \"18 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Equivalent volume to PROCRIT (1 mL) administered every week (QW) for 18 weeks (intravenous or subcutaneous)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Placebo\",\n            \"dosage\": \"1 mL\",\n            \"frequency\": \"QW\",\n            \"start\": \"Week 1\",\n            \"end\": \"Week 18\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Methylphenidate Description: Methylphenidate (OROS-MPH) : Participants will be scheduled for weekly medication (OROS-MPH) and research assessment visits (approximately 45 minutes to 1 hour in length). A forced titration dosing strategy will be used starting with 18 mg\/day OROS-MPH for 3 days, increasing to 36mg\/day for the next three days; increasing to 54 mg\/day in week two, and to 72 mg\/day in week three through the remainder of the study (as tolerated). Participants will also attend weekly CBT sessions (approximately 1 hour in length) targeting their drug use.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"OROS-MPH\",\n        \"dosage\": \"18 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"day 1\",\n        \"end\": \"day 3\"\n    },\n    {\n        \"medication\": \"OROS-MPH\",\n        \"dosage\": \"36 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"day 4\",\n        \"end\": \"day 6\"\n    },\n    {\n        \"medication\": \"OROS-MPH\",\n        \"dosage\": \"54 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 2\",\n        \"end\": \"remainder of study\"\n    },\n    {\n        \"medication\": \"OROS-MPH\",\n        \"dosage\": \"72 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 3\",\n        \"end\": \"remainder of study\"\n    }\n]###"}
{"prompt":"\n    \"Title: Methylphenidate (Placebo) Description: Methylphenidate (OROS-MPH) - Placebo : Participants will be scheduled for weekly medication and research assessment visits (approximately 45 minutes to 1 hour in length). A forced titration dosing strategy will be used starting with 18 mg\/day OROS-MPH placebo for 3 days, increasing to 36mg\/day for the next three days; increasing to 54 mg\/day in week two, and to 72 mg\/day in week three through the remainder of the study (as tolerated). Participants will also attend weekly CBT sessions (approximately 1 hour in length) targeting their drug use.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \u201cplacebo\",\n        \"dosage\": \"18 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 1\",\n        \"end\": \"week 3\"\n    },\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"36 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 1\",\n        \"end\": \"week 3\"\n    },\n    {\n        \"medication\": \u201cplacebo\",\n        \"dosage\": \"54 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 2\",\n        \"end\": \"remainder of study\"\n    },\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"72 mg\/day\",\n        \"frequency\": \"daily\",\n        \"start\": \"week 3\",\n        \"end\": \"remainder of study\"\n    }\n]###"}
{"prompt":"\n    \"Title: 100 IU\/kg \"rhC1INH\" Description: Includes all subjects randomized who received 100 IU\/kg recombinant human C1 inhibitor in the double-blind phase.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"rhC1INH\",\n        \"dosage\": \"100 IU\/kg\",\n        \"frequency\": \"once\",\n        \"start\": \"double-blind phase\",\n        \"end\": \"double-blind phase\"\n}]###"}
{"prompt":"\n    \"Title: 1 Vial (2100 IU) \"rhC1INH\" Description: Includes all subjects who received 1 vial (2100 IU) open-label \"rhC1INH\" in the open-label extension phase.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"rhC1INH\",\n        \"dosage\": \"2100 IU\",\n        \"frequency\": \"once\",\n        \"start\": \"open-label extension phase\",\n        \"end\": \"open-label extension phase\"\n}]###"}
{"prompt":"\n    \"Title: Palifermin Description: Palifermin + Chemotherapy (AI or AP Regimen);\n\nAI = Doxorubicin (Adriamycin) + Ifosfamide:\n\nPalifermin 180 mcg\/kg 3 days prior to chemotherapy; Adriamycin 30 mg\/m^2 intravenous (IV) for 72 hours starting Days 0 for total 90 mg\/m^2. Ifosfamide 2.5 g\/m^2 IV bolus Days 0-3 (total 10 g\/m^2); Vincristine 2 mg IV Day 0.\n\nAP=Doxorubicin (Adriamycin) + Cisplatin:\n\nPalifermin 180 mcg\/kg 3 days prior to chemotherapy; Adriamycin 30 mg\/m^2 IV continuous infusion for 72 hours starting Day 0(total = 90 mg\/m^2); Cisplatin 120 mg\/m^2 on day 0.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Palifermin\",\n        \"dosage\": \"180 mcg\/kg\",\n        \"frequency\": \"3 days prior to chemotherapy\",\n        \"start\": \"\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"Adriamycin\",\n        \"dosage\": \"30 mg\/m^2\",\n        \"frequency\": \"IV for 72 hours starting Days 0 for total 90 mg\/m^2\",\n        \"start\": \"Days 0\",\n        \"end\": \"Days 3\"\n    },\n    {\n        \"medication\": \"Ifosfamide\",\n        \"dosage\": \"2.5 g\/m^2\",\n        \"frequency\": \"IV bolus Days 0-3 (total 10 g\/m^2)\",\n        \"start\": \"Days 0\",\n        \"end\": \"Days 3\"\n    },\n    {\n        \"medication\": \"Vincristine\",\n        \"dosage\": \"2 mg\",\n        \"frequency\": \"IV Day 0\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 0\"\n    },\n    {\n        \"medication\": \"Cisplatin\",\n        \"dosage\": \"120 mg\/m^2\",\n        \"frequency\": \"on day 0\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 0\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib 50 mg (Schedule 4\/2) Description: Sunitinib 50 mg self administered orally, once daily in the morning for 4 consecutive weeks followed by 2 weeks off treatment to comprise a complete 6-weeks cycle.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"morning\",\n        \"end\": \"4 weeks\"\n    },\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"morning\",\n        \"end\": \"2 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Low CIWAar Placebo Description: 20 mg Saline infused slowly over 20 minutes. Placebo 1 capsule Day 1, 2 capsules Day 2, 3 capsules Day 3, 4 capsules days 4 to 30; 3 capsules Day 31 to 33; 2 capsules day 34 to 36 and 1 capsule 37 to 39.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Saline\",\n        \"dosage\": \"20 mg\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 39\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 capsule\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 39\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"2 capsules\",\n        \"frequency\": \"twice\",\n        \"start\": \"Day 2\",\n        \"end\": \"Day 36\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"3 capsules\",\n        \"frequency\": \"thrice\",\n        \"start\": \"Day 3\",\n        \"end\": \"Day 33\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"4 capsules\",\n        \"frequency\": \"daily\",\n        \"start\": \"Day 4\",\n        \"end\": \"Day 30\"\n    }\n]###"}
{"prompt":"\n    \"Title: High CIWAar Placebo Description: 20 mg Saline infused slowly over 20 minutes. Placebo 1 capsule Day 1, 2 capsules Day 2, 3 capsules Day 3, 4 capsules days 4 to 30; 3 capsules Day 31 to 33; 2 capsules day 34 to 36 and 1 capsule 37 to 39.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Saline\",\n        \"dosage\": \"20 mg\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 39\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 capsule\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 39\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"2 capsules\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 2\",\n        \"end\": \"Day 36\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"3 capsules\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 3\",\n        \"end\": \"Day 33\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"4 capsules\",\n        \"frequency\": \"once\",\n        \"start\": \"Day 4\",\n        \"end\": \"Day 30\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Placebo + Chemotherapy (AI or AP Regimen):\n\nAI = Doxorubicin (Adriamycin) + Ifosfamide:\n\nA single dose placebo 3 days prior to chemotherapy; Adriamycin 30 mg\/m^2 intravenous (IV) for 72 hours starting Days 0 for total 90 mg\/m^2. Ifosfamide 2.5 g\/m^2 IV bolus Days 0-3 (total 10 g\/m^2); Vincristine 2 mg IV Day 0.\n\nAP=Doxorubicin (Adriamycin) + Cisplatin:\n\nA single dose placebo 3 days prior to chemotherapy; Adriamycin 30 mg\/m^2 IV continuous infusion for 72 hours starting Day 0(total = 90 mg\/m^2); Cisplatin 120 mg\/m^2 on day 0.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"Once\",\n        \"start\": \"3 days prior to chemotherapy\",\n        \"end\": \"3 days prior to chemotherapy\"\n    },\n    {\n        \"medication\": \"Doxorubicin (Adriamycin)\",\n        \"dosage\": \"30 mg\/m^2\",\n        \"frequency\": \"IV for 72 hours\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 3\"\n    },\n    {\n        \"medication\": \"Ifosfamide\",\n        \"dosage\": \"2.5 g\/m^2\",\n        \"frequency\": \"IV bolus\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 3\"\n    },\n    {\n        \"medication\": \"Vincristine\",\n        \"dosage\": \"2 mg\",\n        \"frequency\": \"IV\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 0\"\n    },\n    {\n        \"medication\": \"Cisplatin\",\n        \"dosage\": \"120 mg\/m^2\",\n        \"frequency\": \"IV\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 0\"\n    }\n]###"}
{"prompt":"\n    \"Title: MenACWY-PS (2-10 Years) Description: Subjects received one dose of the licensed MenACWY-PS vaccine\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"MenACWY-PS\",\n            \"dosage\": \"1 dose\",\n            \"frequency\": \"once\",\n            \"start\": \"2-10 years\",\n            \"end\": \"2-10 years\"\n        }\n]###"}
{"prompt":"\n    \"Title: MenACWY-CRM + PnC (12-15 Months) Description: Subjects received one dose of investigational MenACWY-CRM conjugate vaccine concomitantly with PnC\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"MenACWY-CRM\",\n            \"dosage\": \"1 dose\",\n            \"frequency\": \"concomitantly\",\n            \"start\": \"12-15 Months\",\n            \"end\": \"12-15 Months\"\n        },\n        {\n            \"medication\": \"PnC\",\n            \"dosage\": \"1 dose\",\n            \"frequency\": \"concomitantly\",\n            \"start\": \"12-15 Months\",\n            \"end\": \"12-15 Months\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: MenACWY-CRM + DTaP (16-23 Months) Description: Subjects received one dose of investigational MenACWY-CRM conjugate vaccine concomitantly with DTaP\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"MenACWY-CRM conjugate vaccine\",\n            \"dosage\": \"one dose\",\n            \"frequency\": \"concomitantly\",\n            \"start\": \"16 months\",\n            \"end\": \"23 months\"\n        },\n        {\n            \"medication\": \"DTaP\",\n            \"dosage\": \"one dose\",\n            \"frequency\": \"concomitantly\",\n            \"start\": \"16 months\",\n            \"end\": \"23 months\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Placebo Description: Patients received placebo at Weeks 0 and 4. At Weeks 12 and 16, placebo crossed over to receive ustekinumab 45 mg or 90 mg. Treatments after Week 16 were dependent on clinical response.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Placebo\",\n            \"dosage\": \"NA\",\n            \"frequency\": \"Weeks 0 and 4\",\n            \"start\": \"Week 0\",\n            \"end\": \"Week 4\"\n        },\n        {\n            \"medication\": \"Ustekinumab\",\n            \"dosage\": \"45 mg or 90 mg\",\n            \"frequency\": \"Weeks 12 and 16\",\n            \"start\": \"Week 12\",\n            \"end\": \"Week 16\"\n        }\n]###"}
{"prompt":"\n    \"Title: Ustekinumab 45 mg Description: Patients received ustekinumab 45 mg at Weeks 0, 4 and 16. Treatments after Week 16 were dependent on clinical response. At Week 40, patients who achieved PASI 75 at both Week 28 and Week 40 were re-randomized to withdraw from therapy (placebo) or continue 45 mg every 12 week maintenance therapy.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"45 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 16\"\n    },\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"45 mg\",\n        \"frequency\": \"every 12 weeks\",\n        \"start\": \"Week 40\",\n        \"end\": \"Maintenance therapy\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 1: Ustekinumab 45 mg Withdrawal Group Description: Patients received ustekinumab 45 mg at Weeks 0, 4, 16 and 28.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"45 mg\",\n        \"frequency\": \"Every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 28\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 2: Ustekinumab 45 mg Every 12 Weeks Description: Patients received ustekinumab 45 mg at Weeks 0, 4, 16, 28 and 40.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"45 mg\",\n        \"frequency\": \"Every 12 Weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 40\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 3: Ustekinumab 90 mg Withdrawal Description: Patients received ustekinumab 90 mg at Weeks 0, 4, 16 and 28.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"90 mg\",\n        \"frequency\": \"Once every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 28\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 4: Ustekinumab 90 mg Every 12 Weeks Description: Patients received ustekinumab 90 mg at Weeks 0, 4, 16, 28 and 40.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"90 mg\",\n        \"frequency\": \"Every 12 Weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 40\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 5: Withdrawal Combined Group Description: Groups 1 and 3 (Withdrawal Combined)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \u201cN\/A\",\n        \"dosage\": \u201cN\/A\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\u201d\n    }\n]###"}
{"prompt":"\n    \"Title: Group 6: Combined Ustekinumab Every 12 Weeks Description: Groups 2 and 4 (Combined Ustekinumab every 12 weeks)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"12 weeks\",\n        \"frequency\": \"every 12 weeks\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib 37.5 mg Description: Sunitinib 37.5 mg continuous daily dosing (CDD) self administered orally once daily in the morning.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"37.5 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"morning\",\n        \"end\": \"\"\n}]###"}
{"prompt":"\n    \"Title: All Subjects Description: All subjects\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Ibuprofen\",\n            \"dosage\": \"200mg\",\n            \"frequency\": \"every 6 hours\",\n            \"start\": \"9am\",\n            \"end\": \"9pm\"\n        },\n        {\n            \"medication\": \"Acetaminophen\",\n            \"dosage\": \"500mg\",\n            \"frequency\": \"every 4 hours\",\n            \"start\": \"8am\",\n            \"end\": \"10pm\"\n        },\n        {\n            \"medication\": \"Aspirin\",\n            \"dosage\": \"325mg\",\n            \"frequency\": \"every 8 hours\",\n            \"start\": \"7am\",\n            \"end\": \"11pm\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Arm A: FOLFOX or FOLFIRI + Bevacizumab Description: Patients receive bevacizumab 5 mg\/kg IV every two weeks and then receive either FOLFOX or FOLFIRI every two weeks as described in the intervention section. One cycle is defined as 8 weeks of treatment. Treatment continues until disease progression, unacceptable toxicity or surgery with curative intent as planned.\n\nFOLFOX or: Patients receive oxaliplatin 85 mg\/m^2 IV infused over two hours followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus, then 2400 mg\/m^2 continuous IV infusion over 46-48 hours\n\nFOLFIRI: Patients receive irinotecan 180 mg\/m^2 IV infused over 90 minutes followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus following leucovorin then 2400 mg\/m^2 continuous IV infusion over 46-48 hours.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Bevacizumab\",\n        \"dosage\": \"5 mg\/kg\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"85 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Leucovorin\",\n        \"dosage\": \"400 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"5-FU\",\n        \"dosage\": \"400 mg\/m^2 IV bolus, then 2400 mg\/m^2 continuous IV infusion over 46-48 hours\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Irinotecan\",\n        \"dosage\": \"180 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm B: FOLFOX or FOLFIRI + Cetuximab Description: Patients receive cetuximab 400mg\/m^2 IV over 2 hours on the first day of treatment, then 250 mg\/m^2 IV over 1 hour weekly thereafter. Patients also receive either FOLFOX or FOLFIRI every two weeks as described in the intervention section. One cycle is defined as 8 weeks of treatment. Treatment continues until disease progression, unacceptable toxicity or surgery with curative intent as planned.\n\nFOLFOX or: Patients receive oxaliplatin 85 mg\/m^2 IV infused over two hours followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus, then 2400 mg\/m^2 continuous IV infusion over 46-48 hours\n\nFOLFIRI: Patients receive irinotecan 180 mg\/m^2 IV infused over 90 minutes followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus following leucovorin then 2400 mg\/m^2 continuous IV infusion over 46-48 hours.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Cetuximab\",\n        \"dosage\": \"400mg\/m^2\",\n        \"frequency\": \"once a week\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"85 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Leucovorin\",\n        \"dosage\": \"400 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"5-FU\",\n        \"dosage\": \"400 mg\/m^2 IV bolus, then 2400 mg\/m^2 continuous IV infusion over 46-48 hours\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Irinotecan\",\n        \"dosage\": \"180 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm C: FOLFOX or FOLFIRI + Cetuximab + Bevacizumab Description: Patients receive cetuximab 400mg\/m^2 IV over 2 hours on the first day of treatment, then 250 mg\/m^2 IV over 1 hour weekly thereafter. Also, patients receive bevacizumab 5 mg\/kg IV every two weeks and then receive either FOLFOX or FOLFIRI every two weeks as described in the intervention section. One cycle is defined as 8 weeks of treatment. Treatment continues until disease progression, unacceptable toxicity or surgery with curative intent as planned.\n\nFOLFOX or: Patients receive oxaliplatin 85 mg\/m^2 IV infused over two hours followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus, then 2400 mg\/m^2 continuous IV infusion over 46-48 hours\n\nFOLFIRI: Patients receive irinotecan 180 mg\/m^2 IV infused over 90 minutes followed by leucovorin 400 mg\/m^2 IV over 2 hours followed by 5-FU 400 mg\/m^2 IV bolus following leucovorin then 2400 mg\/m^2 continuous IV infusion over 46-48 hours.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Cetuximab\",\n        \"dosage\": \"400mg\/m^2\",\n        \"frequency\": \"once a week\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Bevacizumab\",\n        \"dosage\": \"5 mg\/kg\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"85 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Leucovorin\",\n        \"dosage\": \"400 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"5-FU\",\n        \"dosage\": \"400 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    },\n    {\n        \"medication\": \"Irinotecan\",\n        \"dosage\": \"180 mg\/m^2\",\n        \"frequency\": \"every two weeks\",\n        \"start\": \"first day of treatment\",\n        \"end\": \"until disease progression, unacceptable toxicity or surgery with curative intent as planned\"\n    }\n]###"}
{"prompt":"\n    \"Title: Rituximab 375 mg\/m^2 Description: Rituximab 375 milligrams per meters squared (mg\/m^2) given as an intravenous infusion once weekly for four weeks (Day 0, Day 7, Day 14, and Day 21)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"375 mg\/m^2\",\n        \"frequency\": \"once weekly\",\n        \"start\": \"Day 0\",\n        \"end\": \"Day 21\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: subjects received placebo for 1 year\n\nPlacebo weekly\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1\",\n        \"frequency\": \"Weekly\",\n        \"start\": \"Now\",\n        \"end\": \"1 year\"\n    }\n]###"}
{"prompt":"\n    \"Title: No Prior Therapy Description: All patients will receive oral ZD1839 250 mg daily. Pill counts will be conducted at every visit to monitor compliance. Treatment will be continued for a minimum of 8 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"ZD1839\",\n        \"dosage\": \"250 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"immediately\",\n        \"end\": \"8 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Prior Chemotherapy Description: All patients will receive oral ZD1839 250 mg daily. Pill counts will be conducted at every visit to monitor compliance. Treatment will be continued for a minimum of 8 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"ZD1839\",\n        \"dosage\": \"250 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"\",\n        \"end\": \"8 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tositumomab and Iodine I-131 Tositumomab Description: Participants were treated with a saturated solution of potassium iodide (KI), Lugol's solution, or KI tablets starting at least 24 hours prior to the first infusion of Iodine I-131 Tositumomab (TST) and continuing for 14 days following the last infusion of Iodine I-131 TST. Participants received treatment in two phases. The dosimetric dose was administered in Phase 1 as 450 milligrams (mg) of TST infused over 1 hour (preceded by the administration of oral acetaminophen and an antihistamine), followed by 5 millicurie (mCi) of Iodine I-131 TST infused over 20 minutes (min), followed by a 10-min normal saline flush. The therapeutic dose, administered 7-14 days after the dosimetric dose, was administered as 450 mg of TST infused over 1 hour (preceded by the administration of oral acetaminophen and an antihistamine), followed by the appropriate activity (mCi) of Iodine I-131 TST infused over 20 min, followed by a 10-min normal saline flush.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tositumomab\",\n        \"dosage\": \"450 mg\",\n        \"frequency\": \"once\",\n        \"start\": \"24 hours prior to first infusion\",\n        \"end\": \"14 days after last infusion\"\n    },\n    {\n        \"medication\": \"Iodine I-131 Tositumomab\",\n        \"dosage\": \"5 mCi\",\n        \"frequency\": \"once\",\n        \"start\": \"24 hours prior to first infusion\",\n        \"end\": \"14 days after last infusion\"\n    }\n]###"}
{"prompt":"\n    \"Title: Zemaira\u00ae Description: Alpha1-proteinase inhibitor: 60 mg\/kg body weight\/week intravenous\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Zemaira\u00ae\",\n            \"dosage\": \"60 mg\/kg body weight\",\n            \"frequency\": \"weekly\",\n            \"start\": \"\",\n            \"end\": \"\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Placebo Description: Lyophilized preparation: 60 mg\/kg body weight\/week intravenous\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"60 mg\/kg body weight\",\n        \"frequency\": \"weekly\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cohort A Arm I: Exemestane Description: Patients receive oral exemestane 25 mg once daily for up to 16-18 weeks prior to partial or radical mastectomy or lumpectomy with or without lymph node dissection\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Exemestane\",\n        \"dosage\": \"25 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"0\",\n        \"end\": \"16-18 weeks\"\n}]###"}
{"prompt":"\n    \"Title: Cohort A Arm II: Letrozole Description: Patients receive oral letrozole 2.5 mg once daily for up to 16-18 weeks prior to partial or radical mastectomy or lumpectomy with or without lymph node dissection\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Letrozole\",\n        \"dosage\": \"2.5 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"0\",\n        \"end\": \"16-18 weeks\"\n}]###"}
{"prompt":"\n    \"Title: Cohort A Arm III: Anastrozole Description: Patients receive oral anastrozole 1 mg once daily for up to 16-18 weeks prior to partial or radical mastectomy or lumpectomy with or without lymph node dissection\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Anastrozole\",\n        \"dosage\": \"1 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"up to 16-18 weeks prior to partial or radical mastectomy or lumpectomy with or without lymph node dissection\",\n        \"end\": \"partial or radical mastectomy or lumpectomy with or without lymph node dissection\"\n}]###"}
{"prompt":"\n    \"Title: Cohort B Arm II: Week 2 Ki67 > 10% Description: Patients who after 2 weeks of neoadjuvant aromatase inhibitor (AI) therapy had a tumor Ki67 level of greater than 10% and switched to neoadjuvant chemotherapy.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Neoadjuvant Aromatase Inhibitor (AI)\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"2 weeks ago\",\n        \"end\": \"Present\"\n    },\n    {\n        \"medication\": \"Neoadjuvant Chemotherapy\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"Present\",\n        \"end\": \"TBD\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cohort B Description: Patients undergo a core breast biopsy for Ki67 determination after 2 weeks of neoadjuvant aromatase inhibitor (AI) therapy. If the Ki67 was \u226410% the patient continued AI therapy for another 12-14 weeks and then proceeded to surgery. Women whose two-week Ki67 level was > 10% were offered either a NCCN approved neoadjuvant chemotherapy regimen or surgery at the discretion of providers\/patients. If the biopsy core contained insufficient tumor to perform the Ki67 assay patients could elect to be re-biopsied at 4 weeks or continue on AI therapy. If severe treatment-related toxicity was reported or the patient refused further AI therapy, surgery was recommended.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Aromatase Inhibitor (AI)\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"2 weeks\",\n        \"start\": \"Start of treatment\",\n        \"end\": \"End of treatment\"\n    },\n    {\n        \"medication\": \"Neoadjuvant Chemotherapy\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"Optional\",\n        \"end\": \"Optional\"\n    }\n]###"}
{"prompt":"\n    \"Title: Gemcitabine + Mitoxantrone Description: Gemcitabine Hydrochloride as administered as a continuous intravenous infusion (I.V.) at 10mg\/m^2\/minute for 12 hours, starting on Day 1. Mitoxantrone Hydrochloride was given at a dose of 12mg\/m^2\/day I.V. on days 1, 2, and 3.\n\nGemcitabine Hydrochloride: 10 mg\/m2\/ min IV for 12 hours\n\nMitoxantrone Hydrochloride: 12 mg\/m2\/day IV (administer over 30-60 minutes) on Day 1, 2 and 3\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Gemcitabine Hydrochloride\",\n        \"dosage\": \"10 mg\/m2\/min\",\n        \"frequency\": \"IV for 12 hours\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 1\"\n    },\n    {\n        \"medication\": \"Mitoxantrone Hydrochloride\",\n        \"dosage\": \"12 mg\/m2\/day\",\n        \"frequency\": \"IV (administer over 30-60 minutes)\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 3\"\n    }\n]###"}
{"prompt":"\n    \"Title: Poor Risk Patients Description: Poor Risk (primary progressive, recurrent, or resistant relapse)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\",\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \"N\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Day 6 Description: Day 6 pre-dose\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\",\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \"N\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Cohort A Description: 750mg lapatinib administered orally twice daily. Cohort A subjects had Eastern Cooperative Oncology Group (ECOG) performance status 0-1, and one or two prior trastuzumab-containing regimens, in total, for treatment of breast cancer in adjuvant and\/or metastatic settings\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Lapatinib\",\n        \"dosage\": \"750mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"now\",\n        \"end\": \"ongoing\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cohorts A and B Description: Overall - Main Study and Extension Phase - 750 mg lapatinib administered orally twice daily\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Lapatinib\",\n            \"dosage\": \"750 mg\",\n            \"frequency\": \"twice daily\",\n            \"start\": \"Main Study and Extension Phase\",\n            \"end\": \"\"\n        }\n]###"}
{"prompt":"\n    \"Title: Arm A: Rituximab Retreatment Description: 1000 mg rituximab intravenous initial treatment on day 1 and day 15 plus 10-25 mg\/week methotrexate followed by re-treatment during weeks 24 -40 consisting of two additional doses of 1000 mg rituximab 14 days apart plus 10-25 mg\/week methotrexate.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"1000 mg\",\n        \"frequency\": \"Intravenous\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 15\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"10-25 mg\/week\",\n        \"frequency\": \"Weekly\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 40\"\n    },\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"1000 mg\",\n        \"frequency\": \"Intravenous\",\n        \"start\": \"Week 24\",\n        \"end\": \"Week 40\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm B: Placebo Retreatment Description: 1000 mg rituximab initial treatment on day 1 and day 15 plus 10-25 mg\/wk methotrexate followed by re-treatment during weeks 24 -40 consisting of two doses of placebo 14 days apart plus 10-25 mg\/wk methotrexate.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"rituximab\",\n        \"dosage\": \"1000 mg\",\n        \"frequency\": \"once\",\n        \"start\": \"day 1\",\n        \"end\": \"day 15\"\n    },\n    {\n        \"medication\": \"methotrexate\",\n        \"dosage\": \"10-25 mg\/wk\",\n        \"frequency\": \"weekly\",\n        \"start\": \"day 1\",\n        \"end\": \"week 40\"\n    },\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"two doses\",\n        \"frequency\": \"14 days apart\",\n        \"start\": \"week 24\",\n        \"end\": \"week 40\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm A: Rituximab Re-treatment Description: 1000 mg rituximab intravenous initial treatment on day 1 and day 15 plus 10-25 mg\/week methotrexate followed by re-treatment during weeks 24 -40 consisting of two additional doses of 1000 mg rituximab 14 days apart plus 10-25 mg\/week methotrexate.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"1000 mg\",\n        \"frequency\": \"intravenous\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 15\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"10-25 mg\/week\",\n        \"frequency\": \"Weekly\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 40\"\n    },\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"1000 mg\",\n        \"frequency\": \"intravenous\",\n        \"start\": \"Week 24\",\n        \"end\": \"Week 40\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cytarabine or Supportive Care Description: Subject's choice of treatment with physician's advice of either supportive care (IV fluids, nutrition, and antibiotics as needed) or cytarabine 20 mg\/m^2 given subcutaneously once daily for 10 consecutive days, repeated every 4 weeks. (These represent one intervention.)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Cytarabine\",\n        \"dosage\": \"20 mg\/m^2\",\n        \"frequency\": \"once daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 10\"\n    },\n    {\n        \"medication\": \"Supportive Care\",\n        \"dosage\": \"IV fluids, nutrition, and antibiotics as needed\",\n        \"frequency\": \"as needed\",\n        \"start\": \"Day 1\",\n        \"end\": \"Ongoing\"\n    }\n]###"}
{"prompt":"\n    \"Title: Treatment Arm - All Subjects Description: poly ICLC, temozolomide, radiation: radiation therapy\n\npoly ICLC : 20 mcg\/kg 3x each week (Maintenance cycles)\n\ntemozolomide : daily 75mg\/m2 6wks concomitant therapy Wk 1 - days 1-5 150-200 mg\/m2 maintenance cycles (adjuvant)\n\nradiation therapy : RT: 60 Gy (6 weeks) concomitant therapy\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"poly ICLC\",\n        \"dosage\": \"20 mcg\/kg\",\n        \"frequency\": \"3x each week\",\n        \"start\": \"Maintenance cycles\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"temozolomide\",\n        \"dosage\": \"daily 75mg\/m2\",\n        \"frequency\": \"6wks concomitant therapy Wk 1 - days 1-5 150-200 mg\/m2 maintenance cycles (adjuvant)\",\n        \"start\": \"\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"radiation therapy\",\n        \"dosage\": \"60 Gy\",\n        \"frequency\": \"6 weeks concomitant therapy\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cProlastin\",\n            \"dosage\": \"60 mg\/kg\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \"N\/A\"\n        }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \u201cN\/A\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\u201d\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Phase 3 (52 Week Assessment of Relapse Phase): matching placebo oral tablets and 250-mg and 300-mg oral lithium tablets or 250-mg Depakote\/valproic acid oral tablets\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"Oral tablets\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 52\"\n    },\n    {\n        \"medication\": \"Lithium\",\n        \"dosage\": \"250-mg and 300-mg oral tablets\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 52\"\n    },\n    {\n        \"medication\": \"Depakote\/valproic acid\",\n        \"dosage\": \"250-mg oral tablets\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 52\"\n    }\n]###"}
{"prompt":"\n    \"Title: Aripiprazole Description: Phase 3 (52 Week Assessment of Relapse Phase): aripiprazole 10-mg and 15-mg oral tablets and 250-mg and 300-mg oral lithium tablets or 250-mg Depakote\/valproic acid oral tablets\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Aripiprazole\",\n        \"dosage\": \"10-mg and 15-mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"52 weeks\",\n        \"end\": \"ongoing\"\n    },\n    {\n        \"medication\": \"Lithium\",\n        \"dosage\": \"250-mg and 300-mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"52 weeks\",\n        \"end\": \"ongoing\"\n    },\n    {\n        \"medication\": \"Depakote\/Valproic Acid\",\n        \"dosage\": \"250-mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"52 weeks\",\n        \"end\": \"ongoing\"\n    }\n]###"}
{"prompt":"\n    \"Title: Lithium Description: Phase 2 (13 to 24 Week Stability and Maintenance of Stability Phase): aripiprazole 10-mg and 15-mg oral tablets and 250-mg and 300-mg oral lithium tablets\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"aripiprazole\",\n            \"dosage\": \"10-mg and 15-mg\",\n            \"frequency\": \"oral tablets\",\n            \"start\": \"13 weeks\",\n            \"end\": \"24 weeks\"\n        },\n        {\n            \"medication\": \"lithium\",\n            \"dosage\": \"250-mg and 300-mg\",\n            \"frequency\": \"oral tablets\",\n            \"start\": \"13 weeks\",\n            \"end\": \"24 weeks\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Valproate Description: Phase 2 (13 to 24 Week Stability and Maintenance of Stability Phase): aripiprazole 10-mg and 15-mg oral tablets and 250-mg Depakote\/valproic acid oral tablets\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"aripiprazole\",\n            \"dosage\": \"10-mg and 15-mg\",\n            \"frequency\": \"oral tablets\",\n            \"start\": \"13 weeks\",\n            \"end\": \"24 weeks\"\n        },\n        {\n            \"medication\": \"Depakote\/valproic acid\",\n            \"dosage\": \"250-mg\",\n            \"frequency\": \"oral tablets\",\n            \"start\": \"13 weeks\",\n            \"end\": \"24 weeks\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Azithromycin Description: Active adjunctive treatment\n\nAzithromycin: 600 mg x 3 days, then 600 mg weekly x 11 weeks\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Azithromycin\",\n        \"dosage\": \"600 mg\",\n        \"frequency\": \"3 days\",\n        \"start\": \"now\",\n        \"end\": \"11 weeks\"\n    },\n    {\n        \"medication\": \"Azithromycin\",\n        \"dosage\": \"600 mg\",\n        \"frequency\": \"weekly\",\n        \"start\": \"3 days\",\n        \"end\": \"11 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Observational Cohort Description: Eligible Participants who declined randomization were offered enrollment in a parallel open-label observational treatment arm\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"None\",\n        \"dosage\": \"None\",\n        \"frequency\": \"None\",\n        \"start\": \"None\",\n        \"end\": \"None\"\n}]###"}
{"prompt":"\n    \"Title: Azithromycin Description: Randomized azithromycin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Azithromycin\",\n        \"dosage\": \"Randomized\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Immediately\",\n        \"end\": \"Until finished\"\n    }\n]###"}
{"prompt":"\n    \"Title: Open-Label Azithromycin Description: Eligible participants who declined randomization were offered enrollment in an open-label observational treatment arm.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Azithromycin\",\n        \"dosage\": \"varies\",\n        \"frequency\": \"varies\",\n        \"start\": \"varies\",\n        \"end\": \"varies\"\n    }\n]###"}
{"prompt":"\n    \"Title: Levocetirizine 5 mg Description: Levocetirizine 5 mg once daily for four weeks\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Levocetirizine\",\n        \"dosage\": \"5 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"now\",\n        \"end\": \"4 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Desloratadine 5 mg Description: Desloratadine 5 mg once daily for four weeks\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Desloratadine\",\n            \"dosage\": \"5 mg\",\n            \"frequency\": \"once daily\",\n            \"start\": \"now\",\n            \"end\": \"four weeks\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Rifaximin Treatment Arm Description: rifaximin 400mg taken 3 times a day\n\nRifaximin (Xifaxan)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Rifaximin\",\n        \"dosage\": \"400mg\",\n        \"frequency\": \"3 times a day\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Vancomycin Comparator Arm Description: vancomycin 125mg taken 4 times a day\n\nVancomycin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"vancomycin\",\n        \"dosage\": \"125mg\",\n        \"frequency\": \"4 times a day\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm 1: Capecitabine + Oxaliplatin Description: Oxaliplatin 130 mg\/m2 IV over 2 hours on day 1 every 21 days for 8 cycles: Arm 1\n\nOral capecitabine 850 mg\/m2 twice daily on days 1-14 every 21 days for 8 cycles: Arm 1\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"130 mg\/m2\",\n        \"frequency\": \"IV over 2 hours on day 1 every 21 days\",\n        \"start\": \"Day 1\",\n        \"end\": \"8 cycles\"\n    },\n    {\n        \"medication\": \"Capecitabine\",\n        \"dosage\": \"850 mg\/m2\",\n        \"frequency\": \"twice daily on days 1-14 every 21 days\",\n        \"start\": \"Day 1\",\n        \"end\": \"8 cycles\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm 2: Floxuridine + Oxaliplatin + Capecitabine Description: Oxaliplatin 130 mg\/m2 IV over 2 hours on day 22 every 42 days for 4 cycles and then on day 1 every 21 days for 4 cycles\n\nOral capecitabine 850 mg\/m2 twice daily on days 22-35 every 42 days for 4 cycles and then on days 1-14 every 21 days for 4 cycles\n\nContinuous hepatic arterial infusion of floxuridine 0.2 mg\/kg on days 1-14 every 42 days for 4 cycles\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"130 mg\/m2\",\n        \"frequency\": \"every 42 days for 4 cycles and then on day 1 every 21 days for 4 cycles\",\n        \"start\": \"day 22\",\n        \"end\": \"day 1\"\n    },\n    {\n        \"medication\": \"Capecitabine\",\n        \"dosage\": \"850 mg\/m2\",\n        \"frequency\": \"every 42 days for 4 cycles and then on days 1-14 every 21 days for 4 cycles\",\n        \"start\": \"days 22-35\",\n        \"end\": \"days 1-14\"\n    },\n    {\n        \"medication\": \"Floxuridine\",\n        \"dosage\": \"0.2 mg\/kg\",\n        \"frequency\": \"every 42 days for 4 cycles\",\n        \"start\": \"days 1-14\",\n        \"end\": \"days 1-14\"\n    }\n]###"}
{"prompt":"\n    \"Title: Asenapine Description: 5-10 mg twice daily (bid) sublingual (SL)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Asenapine\",\n        \"dosage\": \"5-10 mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Olanzapine Description: 5-20 mg daily (QD) orally (PO)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Olanzapine\",\n        \"dosage\": \"5-20 mg\",\n        \"frequency\": \"daily (QD)\",\n        \"start\": \"\",\n        \"end\": \"\"\n}]###"}
{"prompt":"\n    \"Title: Ibuprofen 800 mg Tid Description: Ibuprofen 800mg orally tid for 7 days + one placebo injection daily for 7 days\n\n+ additional 7 days of same therapy based on result of ultrasound at day 7\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ibuprofen\",\n        \"dosage\": \"800mg\",\n        \"frequency\": \"tid\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 7\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 injection\",\n        \"frequency\": \"daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 7\"\n    },\n    {\n        \"medication\": \"Ibuprofen\",\n        \"dosage\": \"800mg\",\n        \"frequency\": \"tid\",\n        \"start\": \"Day 8\",\n        \"end\": \"Day 14\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 injection\",\n        \"frequency\": \"daily\",\n        \"start\": \"Day 8\",\n        \"end\": \"Day 14\"\n    }\n]###"}
{"prompt":"\n    \"Title: Dalteparin 200 U\/kg Then 10,000 U Daily Description: Dalteparin 200 units\/kg subcutaneously injection on day one then 10,000 units daily for 6 additional doses + placebo orally for 7 days\n\n+ additional 7 days of same therapy based on results of ultrasound at day 7\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Dalteparin\",\n        \"dosage\": \"200 U\/kg\",\n        \"frequency\": \"Once\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 1\"\n    },\n    {\n        \"medication\": \"Dalteparin\",\n        \"dosage\": \"10,000 U\",\n        \"frequency\": \"Daily\",\n        \"start\": \"Day 2\",\n        \"end\": \"Day 7\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"N\/A\",\n        \"frequency\": \"Daily\",\n        \"start\": \"Day 2\",\n        \"end\": \"Day 7\"\n    },\n    {\n        \"medication\": \"Dalteparin\",\n        \"dosage\": \"10,000 U\",\n        \"frequency\": \"Daily\",\n        \"start\": \"Day 8\",\n        \"end\": \"Day 14\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"N\/A\",\n        \"frequency\": \"Daily\",\n        \"start\": \"Day 8\",\n        \"end\": \"Day 14\"\n    }\n]###"}
{"prompt":"\n    \"Title: Enzastaurin+Gemcitabine Description: Enzastaurin: 1200 milligrams (mg) administered orally (as three 400-mg doses) after a meal on Day 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 2 to 28 in Cycle 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 1 to 28 in Cycle 2 and later.\n\nGemcitabine: 1000 milligrams\/square meter (mg\/m^2) administered intravenously on Days 1, 8 and 15 of each 28-day cycle.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Enzastaurin\",\n        \"dosage\": \"1200 mg\",\n        \"frequency\": \"three 400-mg doses after a meal on Day 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 2 to 28 in Cycle 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 1 to 28 in Cycle 2 and later.\",\n        \"start\": \"Day 1\",\n        \"end\": \"Cycle 2 and later\"\n    },\n    {\n        \"medication\": \"Gemcitabine\",\n        \"dosage\": \"1000 mg\/m^2\",\n        \"frequency\": \"intravenously on Days 1, 8 and 15 of each 28-day cycle.\",\n        \"start\": \"Day 1\",\n        \"end\": \"28-day cycle\"\n    }\n]###"}
{"prompt":"\n    \"Title: Gemcitabine Description: Gemcitabine: 1000 mg\/m^2 administered intravenously on Days 1, 8 and 15 of each 28-day cycle.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Gemcitabine\",\n        \"dosage\": \"1000 mg\/m^2\",\n        \"frequency\": \"every 28 days\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 15\"\n    }\n]###"}
{"prompt":"\n    \"Title: Decitabine 20 mg\/m2 Intravenous Description: Decitabine 20 mg\/m2 intravenous IV on Days 1-5 of each 28 day cycle.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Decitabine\",\n        \"dosage\": \"20 mg\/m2\",\n        \"frequency\": \"Intravenous IV on Days 1-5 of each 28 day cycle\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 5\"\n}]###"}
{"prompt":"\n    \"Title: Population 1: Placebo SC Followed by Ustekinumab SC Description: Placebo injected subcutaneously (SC) once a week for 4 weeks (Weeks 0-3) during Intervention Period 1 followed by ustekinumab 90 mg SC once a week for 4 weeks (Weeks 8-11) during Intervention Period 2.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"SC\",\n        \"frequency\": \"once a week\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 3\"\n    },\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"90 mg SC\",\n        \"frequency\": \"once a week\",\n        \"start\": \"Week 8\",\n        \"end\": \"Week 11\"\n    }\n]###"}
{"prompt":"\n    \"Title: Population 1: Placebo IV Followed by Ustekinumab 4.5 mg\/kg IV Description: Placebo given as 1 intravenous (IV) infusion at Week 0 during Intervention Period 1 and ustekinumab 4.5 mg\/kg given as one IV infusion at Week 8 during Intervention Period 2.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"1 IV infusion\",\n        \"frequency\": \"Week 0\",\n        \"start\": \"Intervention Period 1\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"ustekinumab\",\n        \"dosage\": \"4.5 mg\/kg IV infusion\",\n        \"frequency\": \"Week 8\",\n        \"start\": \"Intervention Period 2\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Population 1: Placebo SC and IV Combined Description: All particpants who received Placebo SC and Placebo IV\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"    \n    [\n        {\n            \"medication\": \"Placebo\",\n            \"dosage\": \"SC and IV\",\n            \"frequency\": \"Combined\",\n            \"start\": \"N\/A\",\n            \"end\": \"N\/A\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Population 1: Ustekinumab SC and IV Combined Description: All participants who received Ustekinumab 90 mg SC and Ustekinumab 4.5 mg\/kg IV\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"90 mg\",\n        \"frequency\": \"SC\",\n        \"start\": \"\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"4.5 mg\/kg\",\n        \"frequency\": \"IV\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Population 1:Placebo SC Followed by Ustekinumab 90 mg SC Description: Participants received subcutaneous (SC) injections of placebo at Weeks 0, 1, 2, 3 (Intervention Period 1: Weeks 0-8), and 90 mg ustekinumab SC at Weeks 8, 9, 10 and 11 (Intervention Period 2: Weeks 8-28)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"SC\",\n        \"frequency\": \"Weekly\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 8\"\n    },\n    {\n        \"medication\": \"ustekinumab\",\n        \"dosage\": \"90 mg SC\",\n        \"frequency\": \"Weekly\",\n        \"start\": \"Week 8\",\n        \"end\": \"Week 28\"\n    }\n]###"}
{"prompt":"\n    \"Title: Population 1: Ustekinumab SC and IV Combined Description: All participants who received Ustekinumab SC and Ustekinumab IV\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab SC\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"Varies\",\n        \"end\": \"Varies\"\n    },\n    {\n        \"medication\": \"Ustekinumab IV\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"Varies\",\n        \"end\": \"Varies\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Patients in this group received a capsule identical to pentoxifylline that instead contained sucrose thrice daily for 1 year.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sucrose\",\n        \"dosage\": \"1 capsule\",\n        \"frequency\": \"Thrice daily\",\n        \"start\": \"1 year\",\n        \"end\": \"1 year\"\n    }\n]###"}
{"prompt":"\n    \"Title: Active Comparator Description: Gemcitabine + Carboplatin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Gemcitabine\",\n        \"dosage\": \"1000 mg\/m2\",\n        \"frequency\": \"once every 3 weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"end of treatment\"\n    },\n    {\n        \"medication\": \"Carboplatin\",\n        \"dosage\": \"AUC 5\",\n        \"frequency\": \"once every 3 weeks\",\n        \"start\": \"start of treatment\",\n        \"end\": \"end of treatment\"\n    }\n]###"}
{"prompt":"\n    \"Title: Experimental Description: Gefitinib\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Gefitinib\",\n        \"dosage\": \"250 mg\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Immediately\",\n        \"end\": \"Continuous\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cyclosporin A Description: The first administration of Cyclosporin A (CsA) was within the first 24 hours post-transplantation at an initial dose of 10-15mg\/kg\/day in 2 divided doses (twice daily at 12-hour interval) either orally, via a nasogastric (NG) tube or intravenously (i.v). Twice daily (b.i.d.) administration was maintained throughout the study period. During the study, it was recommended that the dose of CsA was adjusted, as necessary, to achieve and maintain the C2 or C0 blood CsA concentration within the target ranges.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Cyclosporin A\",\n        \"dosage\": \"10-15mg\/kg\/day\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"first 24 hours post-transplantation\",\n        \"end\": \"study period\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tacrolimus Description: Tacrolimus was administered within the first 24 hours post-transplantation at an initial dose of 0.1-0.15 mg\/kg\/day in 2 divided doses (twice daily at 12-hour interval) either orally or via a nasogastric (NG) tube or intravenously (i.v). Twice daily (b.i.d.) administration was maintained throughout the study period. During the course of the study, the dose of tacrolimus was adjusted as necessary to achieve and maintain the C0 tacrolimus concentrations within target ranges.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tacrolimus\",\n        \"dosage\": \"0.1-0.15 mg\/kg\/day\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"within the first 24 hours post-transplantation\",\n        \"end\": \"throughout the study period\"\n    }\n]###"}
{"prompt":"\n    \"Title: Topotecan Hydrochloride Description: Subjects received IV weekly Topotecan administered at either 2.5 mg\/m2(if the subject had prior pelvic radiotherapy) or 3.0 mg\/m2 on Days 1, 8 and 15(+ or - 2 days) every 28 days.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Topotecan Hydrochloride\",\n        \"dosage\": \"2.5 mg\/m2 or 3.0 mg\/m2\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 15 (+ or - 2 days)\"\n    }\n]###"}
{"prompt":"\n    \"Title: GW815SF 50\/500 \u00b5g Description: Participants received one inhalation of GW815SF 50\/500 \u00b5g (50 \u00b5g salmeterol and 500 \u00b5g fluticasone propionate) twice daily for 52 weeks. Participants also received Salbutamol sulfate aerosol as a rescue medication on an as-needed basis.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"GW815SF\",\n        \"dosage\": \"50\/500 \u00b5g\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"52 weeks\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"Salbutamol sulfate aerosol\",\n        \"dosage\": \"as-needed\",\n        \"frequency\": \"\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Olanzapine + Mood Stabilizer Description: Olanzapine extension for Study BMAC patients who discontinued at Visit 4 or 5. Patients received an initial dose of olanzapine 10 mg for 1 week and subsequent doses of olanzapine 5-20 mg for 17 weeks. Patients received one (1) mood stabilizer (lithium, valproate or carbamazepine) for 18 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Olanzapine\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"Once a week\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 17\"\n    },\n    {\n        \"medication\": \"Mood Stabilizer\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 18\"\n    }\n]###"}
{"prompt":"\n    \"Title: Olanzapine Monotherapy Description: Olanzapine extension for Study BMAC patients who completed Visit 8. Patients received olanapine 5-20 mg for 18 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Olanzapine\",\n        \"dosage\": \"5-20 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"Visit 8\",\n        \"end\": \"18 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Olanzapine + Mood Stabilizer Description: Olanzapine extension for Study BMAC patients who discontinued at Visit 4 or 5. Patients received an initial dose of olanzapine 10 mg for 1 week and subsequent doses of olanzapine 5-20 mg for 17 weeks. Patients received one (1) mood stabilizer (lithium, valproate or carbamazepine) for 18 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Olanzapine\",\n            \"dosage\": \"10 mg\",\n            \"frequency\": \"1 week\",\n            \"start\": \"Visit 4 or 5\",\n            \"end\": \"17 weeks\"\n        },\n        {\n            \"medication\": \"Mood Stabilizer\",\n            \"dosage\": \"Varies\",\n            \"frequency\": \"18 weeks\",\n            \"start\": \"Visit 4 or 5\",\n            \"end\": \"18 weeks\"\n        }\n]###"}
{"prompt":"\n    \"Title: 1) Seeking Safety + Sertraline Description: Seeking Safety + Sertraline\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Seeking Safety\",\n            \"dosage\": \"1 hour session\",\n            \"frequency\": \"once a week\",\n            \"start\": \"immediately\",\n            \"end\": \"ongoing\"\n        },\n        {\n            \"medication\": \"Sertraline\",\n            \"dosage\": \"50mg\",\n            \"frequency\": \"once a day\",\n            \"start\": \"immediately\",\n            \"end\": \"ongoing\"\n        }\n]###"}
{"prompt":"\n    \"Title: 2) Seeking Safety + Placebo Description: Seeking Safety + Placebo\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Seeking Safety\",\n        \"dosage\": \"1 tablet\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"8am\",\n        \"end\": \"8pm\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1 tablet\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"8am\",\n        \"end\": \"8pm\"\n    }\n]###"}
{"prompt":"\n    \"Title: Day 7 Description: Day 7 pre-dose\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: UK234+ (MenACWY Ad+ at 2, 3, 4 m) Description: Three doses of MenACWY conjugate vaccine with adjuvant vaccine were given at 1-month intervals concomitantly with DTaPHibIPV at 2, 3, and 4 months of age. A fourth dose of MenACWY Ad+ was given at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant vaccine\",\n        \"dosage\": \"Three doses\",\n        \"frequency\": \"1-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"DTaPHibIPV\",\n        \"dosage\": \"Three doses\",\n        \"frequency\": \"1-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+\",\n        \"dosage\": \"One dose\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA246+ (MenACWY Ad+ at 2, 4, 6 m) Description: Three doses of MenACWY conjugate vaccine with adjuvant were given at 2-month intervals concomitantly with DTaPHibIPV, HBV, and Prevnar at 2, 4, and 6 months of age (Prevnar at 6 months was optional and was given if available). One subgroup of subjects was given a reduced dose of MenACWY PS vaccine concomitantly with MMR (and Prevnar, if available) at 12 months of age. Another subgroup was administered one dose of MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"MenACWY conjugate vaccine\",\n            \"dosage\": \"3 doses\",\n            \"frequency\": \"2-month intervals\",\n            \"start\": \"2 months\",\n            \"end\": \"6 months\"\n        },\n        {\n            \"medication\": \"MenACWY PS vaccine\",\n            \"dosage\": \"reduced dose\",\n            \"frequency\": \"1 dose\",\n            \"start\": \"12 months\",\n            \"end\": \"12 months\"\n        },\n        {\n            \"medication\": \"MMR\",\n            \"dosage\": \"1 dose\",\n            \"frequency\": \"1 dose\",\n            \"start\": \"12 months\",\n            \"end\": \"12 months\"\n        }\n]###"}
{"prompt":"\n    \"Title: UK234+ (MenACWY Ad+ at 2, 3, 4 m) Description: Three doses of MenACWY conjugate vaccine with adjuvant were given at 1-month intervals concomitantly with DTaPHibIPV at 2, 3, and 4 months of age. A fourth dose of MenACWY Ad+ was given at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"Three doses\",\n        \"frequency\": \"1-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+\",\n        \"dosage\": \"One dose\",\n        \"frequency\": \"Once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA246+ (MenACWY Ad+ at 2, 4, 6m) Description: Three doses of MenACWY conjugate vaccine with adjuvant were given at 2-month intervals concomitantly with DTaPHibIPV, HBV, and Prevnar at 2, 4, and 6 months of age (Prevnar at 6 months was optional and was given if available). One subgroup of subjects was given a reduced dose of MenACWY PS vaccine concomitantly with MMR (and Prevnar, if available) at 12 months of age. Another subgroup was administered one dose of MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine\",\n        \"dosage\": \"3 doses\",\n        \"frequency\": \"2-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"6 months\"\n    },\n    {\n        \"medication\": \"DTaPHibIPV\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"2-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"6 months\"\n    },\n    {\n        \"medication\": \"HBV\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"2-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"6 months\"\n    },\n    {\n        \"medication\": \"Prevnar\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"2-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"6 months\"\n    },\n    {\n        \"medication\": \"MenACWY PS vaccine\",\n        \"dosage\": \"1 reduced dose\",\n        \"frequency\": \"concomitantly with MMR\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    },\n    {\n        \"medication\": \"MMR\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"concomitantly with MenACWY PS vaccine\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    },\n    {\n        \"medication\": \"Prevnar\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"concomitantly with MMR\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA24+ (MenACWY Ad+ at 2, 4 m) Description: Two doses of MenACWY conjugate vaccine with adjuvant were given at a 2-month interval concomitantly with DTaPHibIPV, HBV, and Prevnar at 2 and 4 months of age.\n\nOne dose of MenACWY Ad+ vaccine or one reduced dose (one fifth) of MenACWY PS vaccine was given concomitantly with MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"2 doses\",\n        \"frequency\": \"2-month interval\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+ vaccine\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    },\n    {\n        \"medication\": \"MenACWY PS vaccine\",\n        \"dosage\": \"1 reduced dose (one fifth)\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA24+ (MenACWY Ad+ at 2, 4 m) Description: Two doses of MenACWY conjugate vaccine with adjuvant were given at a 2-month interval concomitantly with DTaPHibIPV, HBV, and Prevnar at 2 and 4 months of age. One dose of MenACWY Ad+ vaccine or one reduced dose of MenACWY PS vaccine was given concomitantly with MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"Two doses\",\n        \"frequency\": \"2-month interval\",\n        \"start\": \"2 months of age\",\n        \"end\": \"4 months of age\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+ vaccine\",\n        \"dosage\": \"One dose\",\n        \"frequency\": \"Once\",\n        \"start\": \"12 months of age\",\n        \"end\": \"12 months of age\"\n    }\n]###"}
{"prompt":"\n    \"Title: UK234+ (MenACWY Ad+ at 2, 3, 4 m) Description: Three doses of MenACWY conjugate vaccine with adjuvant were given at 1-month intervals concomitantly with DTaPHibIPV at 2, 3, and 4 months of age. A fourth dose of MenACWY Ad+ was given at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"Three doses\",\n        \"frequency\": \"1-month intervals\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+\",\n        \"dosage\": \"One dose\",\n        \"frequency\": \"Once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: UK24+ (MenACWY Ad+ at 2, 4 m) Description: Two doses of MenACWY conjugate vaccine with adjuvant were given at a 2-month interval concomitantly with DTaPHibIPV at 2 and 4 months of age. A third dose of MenACWY Ad+ vaccine was given at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"Two doses\",\n        \"frequency\": \"at a 2-month interval\",\n        \"start\": \"2 months of age\",\n        \"end\": \"4 months of age\"\n    },\n    {\n        \"medication\": \"DTaPHibIPV\",\n        \"dosage\": \"Two doses\",\n        \"frequency\": \"at a 2-month interval\",\n        \"start\": \"2 months of age\",\n        \"end\": \"4 months of age\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+ vaccine\",\n        \"dosage\": \"One dose\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months of age\",\n        \"end\": \"12 months of age\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA24+ (MenACWY Ad+ at 2, 4 m) Description: Two doses of MenACWY conjugate vaccine with adjuvant were given at a 2-month interval concomitantly with DTaPHibIPV, HBV, and Prevnar at 2 and 4 months of age.\n\nOne dose of MenACWY Ad+ vaccine or one reduced dose ( of MenACWY PS vaccine was given concomitantly with MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"MenACWY conjugate vaccine with adjuvant\",\n        \"dosage\": \"2 doses\",\n        \"frequency\": \"2-month interval\",\n        \"start\": \"2 months of age\",\n        \"end\": \"4 months of age\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+ vaccine\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months of age\",\n        \"end\": \"12 months of age\"\n    }\n]###"}
{"prompt":"\n    \"Title: CA246+ (MenACWY Ad+ at 2, 4, 6m) Description: Three doses of MenACWY conjugate vaccine with adjuvant were given at 2-month intervals concomitantly with DTaPHibIPV, HBV, and Prevnar at 2, 4, and 6 months of age (Prevnar at 6 months was optional and was given if available). One subgroup of subjects was to be given a reduced dose of MenACWY PS vaccine concomitantly with MMR (and Prevnar, if available) at 12 months of age. Another subgroup was administered one dose of MMR (and Prevnar, if available) at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"MenACWY conjugate vaccine\",\n            \"dosage\": \"standard dose\",\n            \"frequency\": \"2-month intervals\",\n            \"start\": \"2 months\",\n            \"end\": \"6 months\"\n        },\n        {\n            \"medication\": \"MenACWY PS vaccine\",\n            \"dosage\": \"reduced dose\",\n            \"frequency\": \"once\",\n            \"start\": \"12 months\",\n            \"end\": \"12 months\"\n        },\n        {\n            \"medication\": \"MMR\",\n            \"dosage\": \"standard dose\",\n            \"frequency\": \"once\",\n            \"start\": \"12 months\",\n            \"end\": \"12 months\"\n        },\n        {\n            \"medication\": \"Prevnar\",\n            \"dosage\": \"standard dose\",\n            \"frequency\": \"once\",\n            \"start\": \"6 months\",\n            \"end\": \"12 months\"\n        },\n        {\n            \"medication\": \"DTaPHibIPV\",\n            \"dosage\": \"standard dose\",\n            \"frequency\": \"2-month intervals\",\n            \"start\": \"2 months\",\n            \"end\": \"6 months\"\n        },\n        {\n            \"medication\": \"HBV\",\n            \"dosage\": \"standard dose\",\n            \"frequency\": \"2-month intervals\",\n            \"start\": \"2 months\",\n            \"end\": \"6 months\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: NAFLD - Niacin Description: subjects with elevated levels of intra-hepatic trigleceride given a 16 week course of niacin.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Niacin\",\n        \"dosage\": \"500mg\",\n        \"frequency\": \"Twice daily\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 16\"\n    }\n]###"}
{"prompt":"\n    \"Title: UKMenC (Menjugate at 2, 4 m) Description: Two doses of Menjugate were given at a 2-month interval concomitantly with DTaPHibIPV at 2 and 4 months of age. One dose of MenACWY Ad+ vaccine was given at 12 months of age.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Menjugate\",\n        \"dosage\": \"2 doses\",\n        \"frequency\": \"2-month interval\",\n        \"start\": \"2 months\",\n        \"end\": \"4 months\"\n    },\n    {\n        \"medication\": \"MenACWY Ad+ vaccine\",\n        \"dosage\": \"1 dose\",\n        \"frequency\": \"once\",\n        \"start\": \"12 months\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: Cinacalcet Description: cinacalcet hydrochloride. Participants received a starting dose of 30 mg cinacalcet daily (QD). Dose adjustments were based upon repeated measurements of intact parathyroid hormone, calcium serum concentrations, and participant safety information.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Cinacalcet\",\n        \"dosage\": \"30 mg\",\n        \"frequency\": \"Daily\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }]###"}
{"prompt":"\n    \"Title: Group I: Placebo Description: Participants received subcutaneous (SC) placebo injection at Weeks 0, 1,2, and 3. At Week (Wk) 12 and Wk 16, placebo participants crossed over to receive ustekinumab (CNTO 1275) SC.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"SC injection\",\n        \"frequency\": \"Weeks 0, 1, 2, 3\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 3\"\n    },\n    {\n        \"medication\": \"Ustekinumab (CNTO 1275)\",\n        \"dosage\": \"SC injection\",\n        \"frequency\": \"Weeks 12, 16\",\n        \"start\": \"Week 12\",\n        \"end\": \"Week 16\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group II: Ustekinumab x 4 Description: Participants received SC injection of ustekinumab 90 mg at Wk 0,1,2, and 3. At Wk 12 and Wk 16, participants received placebo SC to maintain the blind. After the first 36 participants were randomized, Centocor became aware that some vials of other study agents not used in this study contained black particulate matter and the filtration procedure was implemented. The resulting dose of ustekinumab after filtration was approximately 0.70 mL, equivalent to 63 mg.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"90 mg\",\n        \"frequency\": \"SC injection\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 3\"\n    },\n    {\n        \"medication\": \"Ustekinumab\",\n        \"dosage\": \"63 mg\",\n        \"frequency\": \"SC injection\",\n        \"start\": \"Week 12\",\n        \"end\": \"Week 16\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 1: Placebo + Methotrexate Description: Placebo subcutaneous (SC) injections every 4 weeks from Week 0 to Week 20 (early escape at Week 16); Methotrexate - 15 to 25mg weekly from Week 0 up to 5 yrs; Golimumab - if early escape, 50mg SC injections every 4 weeks from Week 16 up to 5 years; Golimumab - 50 mg SC injections every 4 weeks from Week 24 up to 5 yrs (unless early escape); Methotrexate - Dr's discretion, weekly dose adjusted after unblinding; Golimumab - Dr's discretion after unblinding, dose adjusted from 50 to 100mg and from 100 to 50mg. Duration of the blinded period was until the week-52 database lock.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"SC injections\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 20\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"15 to 25mg\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Week 0\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 16 (early escape)\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 to 100mg or 100 to 50mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 24\",\n        \"end\": \"5 years\"\n    }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Morphine\",\n        \"dosage\": \"15mg\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\"\n    }\n]###"}
{"prompt":"\n    \"Title: AZD2171 30 mg Anti HT Description: AZD2171 30 mg AntiHT prophylaxis\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"AZD2171\",\n            \"dosage\": \"30 mg\",\n            \"frequency\": \u201cN\/A\u201d,\n            \"start\": \u201cN\/A\",\n            \"end\": \u201cN\/A\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: AZD2171 45 mg Anti HT Description: AZD2171 45 mg AntiHT prophylaxis\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"AZD2171\",\n            \"dosage\": \"45 mg\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \"N\/A\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Treatment With Study Drugs Description: Treatment with combination of oxaliplatin and capecitabine using study dose and schedule.\n\nOxaliplatin, Capecitabine : Agent, DOSE AND SCHEDULE (28-days cycle):\n\nOxaliplatin 85 mg\/m2 IV on days 1 and 15 Capecitabine 1500 mg PO BID on days 1-7 and 15-21\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Oxaliplatin\",\n        \"dosage\": \"85 mg\/m2\",\n        \"frequency\": \"IV on days 1 and 15\",\n        \"start\": \"day 1\",\n        \"end\": \"day 15\"\n    },\n    {\n        \"medication\": \"Capecitabine\",\n        \"dosage\": \"1500 mg\",\n        \"frequency\": \"PO BID on days 1-7 and 15-21\",\n        \"start\": \"day 1\",\n        \"end\": \"day 21\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm I (Placebo, Paclitaxel, Carboplatin) Description: Control therapy:\n\nCycles 1-6 received paclitaxel, 175 mg\/m2 plus carboplatin AUC 6 plus placebo (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received placebo every 3 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Paclitaxel\",\n        \"dosage\": \"175 mg\/m2\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"Cycle 1\",\n        \"end\": \"Cycle 6\"\n    },\n    {\n        \"medication\": \"Carboplatin\",\n        \"dosage\": \"AUC 6\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"Cycle 1\",\n        \"end\": \"Cycle 6\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"Cycle 2\",\n        \"end\": \"Cycle 22\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm II (Placebo, Paclitaxel, Carboplatin, Bevacizumab) Description: Bevacizumab-initiation therapy:\n\nCycles 1-6 received paclitaxel, 175 mg\/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg\/kg (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received placebo every 3 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"paclitaxel\",\n        \"dosage\": \"175 mg\/m2\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"cycle 1\",\n        \"end\": \"cycle 6\"\n    },\n    {\n        \"medication\": \"carboplatin\",\n        \"dosage\": \"AUC 6\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"cycle 1\",\n        \"end\": \"cycle 6\"\n    },\n    {\n        \"medication\": \"bevacizumab\",\n        \"dosage\": \"15 mg\/kg\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"cycle 2\",\n        \"end\": \"cycle 6\"\n    },\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"\",\n        \"frequency\": \"every 3 weeks\",\n        \"start\": \"cycle 7\",\n        \"end\": \"cycle 22\"\n    }\n]###"}
{"prompt":"\n    \"Title: Arm III (Paclitaxel, Carboplatin, Bevacizumab) Description: Bevacizumab-throughout therapy:\n\nCycles 1-6 received paclitaxel, 175 mg\/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg\/kg (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received bevacizumab, 15 mg\/kg every 3 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":" [\n        {\n            \"medication\": \"Paclitaxel\",\n            \"dosage\": \"175 mg\/m2\",\n            \"frequency\": \"every 3 weeks\",\n            \"start\": \"Cycle 1\",\n            \"end\": \"Cycle 6\"\n        },\n        {\n            \"medication\": \"Carboplatin\",\n            \"dosage\": \"AUC 6\",\n            \"frequency\": \"every 3 weeks\",\n            \"start\": \"Cycle 1\",\n            \"end\": \"Cycle 6\"\n        },\n        {\n            \"medication\": \"Bevacizumab\",\n            \"dosage\": \"15 mg\/kg\",\n            \"frequency\": \"every 3 weeks\",\n            \"start\": \"Cycle 2\",\n            \"end\": \"Cycle 22\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Chemotherapy With Temozolomide and Radiotherapy Description: Oral temozolomide 75mg\/m2\/day for 14 days, during radiation treatment, and later on temozolomide 100mg\/m2\/day at 14 days on\/14 days off, until unacceptable toxicity or evidence of disease progression for up to 6 cycles from initial treatment. Radiotherapy (as in Intervention 2).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Temozolomide\",\n        \"dosage\": \"75mg\/m2\/day\",\n        \"frequency\": \"14 days\",\n        \"start\": \"initial treatment\",\n        \"end\": \"unacceptable toxicity or evidence of disease progression\"\n    },\n    {\n        \"medication\": \"Temozolomide\",\n        \"dosage\": \"100mg\/m2\/day\",\n        \"frequency\": \"14 days on\/14 days off\",\n        \"start\": \"initial treatment\",\n        \"end\": \"unacceptable toxicity or evidence of disease progression\"\n    },\n    {\n        \"medication\": \"Radiotherapy\",\n        \"dosage\": \"N\/A\",\n        \"frequency\": \"N\/A\",\n        \"start\": \"initial treatment\",\n        \"end\": \"unacceptable toxicity or evidence of disease progression\"\n    }\n]###"}
{"prompt":"\n    \"Title: Radiotherapy Alone Description: 2 regimens are allowed: a) 20 fractions of 2 Gray each, on days 1 to 5, 8 to 12, 15 to 19, and 22 to 26; b) 10 fractions of 3 Gray each, administered on days 1 to 5 and 8 to 12.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Radiotherapy\",\n        \"dosage\": \"2 Gray\",\n        \"frequency\": \"20 fractions\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 26\"\n    },\n    {\n        \"medication\": \"Radiotherapy\",\n        \"dosage\": \"3 Gray\",\n        \"frequency\": \"10 fractions\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 12\"\n    }\n]###"}
{"prompt":"\n    \"Title: Ziprasidone Description: Titrated over a 2-week period, starting with an evening dose of 20 mg\/day, and subsequent dose increases of 20 mg\/day every second day up to a target dose of 80 to 160 mg\/day for subjects weighing > = 45 kg. For subjects with a body weight < 45 kg, the maximum permitted dose was 80 mg\/day (40 mg BID). Doses could have been reduced to a minimum of 40 mg\/day (20 mg BID).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ziprasidone\",\n        \"dosage\": \"20 mg\/day\",\n        \"frequency\": \"every second day\",\n        \"start\": \"evening\",\n        \"end\": \"80 to 160 mg\/day for subjects weighing > = 45 kg, 80 mg\/day for subjects with a body weight < 45 kg\"\n    }\n]###"}
{"prompt":"\n    \"Title: LPV\/r 800\/200 mg QD SGC (Through Week 8) Description: lopinavir\/ritonavir 800\/200 mg once daily (QD) soft gel capsule (SGC)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"lopinavir\/ritonavir\",\n        \"dosage\": \"800\/200 mg\",\n        \"frequency\": \"once daily (QD)\",\n        \"start\": \"now\",\n        \"end\": \"Week 8\"\n    }\n]###"}
{"prompt":"\n    \"Title: Lenalidomide Description: 10 mg\/day, orally once a day for 28 days\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Lenalidomide\",\n            \"dosage\": \"10 mg\",\n            \"frequency\": \"once a day\",\n            \"start\": \"day 1\",\n            \"end\": \"day 28\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Pegylated Liposomal Doxorubicin (PLD) Description: PLD 50 mg\/m^2 was administered intravenously once every 28 days. Each cycle was repeated until progress or unacceptable toxicity.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Pegylated Liposomal Doxorubicin (PLD)\",\n        \"dosage\": \"50 mg\/m^2\",\n        \"frequency\": \"once every 28 days\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }]###"}
{"prompt":"\n    \"Title: Capecitabine Description: Capecitabine 1250 mg\/m^2, in tablets of 150 mg and 500 mg, was administered orally twice daily (BID) for 14 consecutive days followed by a 7-day rest period. Each cycle was repeated every 21 days until progress or unacceptable toxicity.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Capecitabine\",\n        \"dosage\": \"1250 mg\/m^2\",\n        \"frequency\": \"twice daily (BID)\",\n        \"start\": \"14 consecutive days\",\n        \"end\": \"7-day rest period\"\n    }\n]###"}
{"prompt":"\n    \"Title: Valganciclovir Description: 900mg PO qd\n\nValganciclovir : 900mg PO qd x 8 weeks followed by 4 weeks of observation on background antiretroviral (ARV) regimen alone.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Valganciclovir\",\n        \"dosage\": \"900mg\",\n        \"frequency\": \"PO qd\",\n        \"start\": \"now\",\n        \"end\": \"8 weeks\"\n    },\n    {\n        \"medication\": \"ARV regimen\",\n        \"dosage\": \"background\",\n        \"frequency\": \"alone\",\n        \"start\": \"8 weeks\",\n        \"end\": \"12 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Run-in Period Description: The run-in period was designed to determine tolerability of BTDS 20. Subjects were eligible to enter the double-blind phase if they tolerated BTDS 20 and achieved stable analgesia.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"BTDS 20\",\n        \"dosage\": \"Tolerable\",\n        \"frequency\": \"Stable Analgesia\",\n        \"start\": \"Run-in Period\",\n        \"end\": \"Double-Blind Phase\"\n    }\n]###"}
{"prompt":"\n    \"Title: Rituximab, High-Dose Methotrexate & Leucovorin Treatment Description: Induction treatment cycles with rituximab, high-dose methotrexate and leucovorin will be administered every 2 weeks for 6 cycles. Two additional consolidation cycles of high-dose methotrexate without rituximab will be administered at 4 weeks and 8 weeks following completion of the combined therapy.\n\nMethotrexate: 6000 mg\/m^2 will be administered by intravenous infusion over 4 hours after confirming that the recipient patients urine pH is within the range greater than or equal to 7 to less than or equal to 8, and urine output is greater than or equal to 100 mL\/hour.\n\nRituximab: 375 mg\/m^2 intravenous (IV) day 1 of each cycle prior to administration of high-dose methotrexate\n\nLeucovorin: Leucovorin calcium doses will be administered orally or by short intravenous (IV) infusion over 15 minutes\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"6000 mg\/m^2\",\n        \"frequency\": \"every 2 weeks for 6 cycles\",\n        \"start\": \"day 1 of each cycle\",\n        \"end\": \"8 weeks following completion of the combined therapy\"\n    },\n    {\n        \"medication\": \"Rituximab\",\n        \"dosage\": \"375 mg\/m^2\",\n        \"frequency\": \"every 2 weeks for 6 cycles\",\n        \"start\": \"day 1 of each cycle\",\n        \"end\": \"8 weeks following completion of the combined therapy\"\n    },\n    {\n        \"medication\": \"Leucovorin\",\n        \"dosage\": \"varies\",\n        \"frequency\": \"every 2 weeks for 6 cycles\",\n        \"start\": \"day 1 of each cycle\",\n        \"end\": \"8 weeks following completion of the combined therapy\"\n    }\n]###"}
{"prompt":"\n    \"Title: Maintenance Description: All patients enrolled who continued into the maintenance period\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Overall Description: Combination of titration and maintenance period\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Group 1 (Everolimus) Description: Reduced or discontinued CNI dose + everolimus (3-12 ng\/mL) \u00b1 steroids\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Everolimus\",\n        \"dosage\": \"3-12 ng\/mL\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"As prescribed\",\n        \"end\": \"As prescribed\"\n    },\n    {\n        \"medication\": \"Steroids\",\n        \"dosage\": \"As prescribed\",\n        \"frequency\": \"As prescribed\",\n        \"start\": \"As prescribed\",\n        \"end\": \"As prescribed\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 2 (Control) Description: Standard CNI dose \u00b1 mycophenolate acid (MPA)\/azathioprine (AZA) \u00b1 steroids\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"    \n    [\n        {\n            \"medication\": \"Standard CNI dose\",\n            \"dosage\": \"\",\n            \"frequency\": \"\",\n            \"start\": \"\",\n            \"end\": \"\"\n        },\n        {\n            \"medication\": \"Mycophenolate Acid (MPA)\",\n            \"dosage\": \"\",\n            \"frequency\": \"\",\n            \"start\": \"\",\n            \"end\": \"\"\n        },\n        {\n            \"medication\": \"Azathioprine (AZA)\",\n            \"dosage\": \"\",\n            \"frequency\": \"\",\n            \"start\": \"\",\n            \"end\": \"\"\n        },\n        {\n            \"medication\": \"Steroids\",\n            \"dosage\": \"\",\n            \"frequency\": \"\",\n            \"start\": \"\",\n            \"end\": \"\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Pregabalin Description: Subjects who met all eligibility criteria initiated open-label treatment at 150 mg\/day (75 mg BID). Further adjustments of total daily dose within the dose range 150 to 600 mg\/day (BID) were permitted throughout the study to optimize pain control and minimize adverse events (AEs).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Pregabalin\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Day 1\",\n        \"end\": \"Throughout the study\"\n    },\n    {\n        \"medication\": \"Pregabalin\",\n        \"dosage\": \"600 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Throughout the study\",\n        \"end\": \"Throughout the study\"\n    }\n]###"}
{"prompt":"\n    \"Title: GAD : Niravam+SSRI\/SNRI Description: Generalized Anxiety Disorder: Niravam plus newly prescribed SSRI or SNRI\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Niravam\",\n            \"dosage\": \"2mg\",\n            \"frequency\": \"Once daily\",\n            \"start\": \"Immediately\",\n            \"end\": \"Indefinitely\"\n        },\n        {\n            \"medication\": \"SSRI\/SNRI\",\n            \"dosage\": \"20mg\",\n            \"frequency\": \"Once daily\",\n            \"start\": \"Immediately\",\n            \"end\": \"Indefinitely\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Eribulin Mesylate Dose Finding Plus Carboplatin AUC 5 Description: Eribulin mesylate dose finding plus carboplatin AUC 5 in subjects with advanced solid tumors\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Eribulin Mesylate\",\n            \"dosage\": \"Dose Finding\",\n            \"frequency\": \"Once\",\n            \"start\": \"At the start of the study\",\n            \"end\": \"At the end of the study\"\n        },\n        {\n            \"medication\": \"Carboplatin\",\n            \"dosage\": \"AUC 5\",\n            \"frequency\": \"Once\",\n            \"start\": \"At the start of the study\",\n            \"end\": \"At the end of the study\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Testosterone Replacement Therapy Description: Treatment group: Testosterone Replacement Therapy Patch 5 or 10mg daily (Androderm, Watson Pharma Inc.) for 12 months, with the dose adjusted to raise the serum testosterone concentration to within the normal range.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Testosterone Replacement Therapy Patch\",\n        \"dosage\": \"5 or 10mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"now\",\n        \"end\": \"12 months\"\n    }\n]###"}
{"prompt":"\n    \"Title: Testosterone Replacement Therapy Description: Testosterone Replacement Therapy Patch 5 or 10 mg daily\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Testosterone Replacement Therapy Patch\",\n        \"dosage\": \"5 or 10 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Standard Therapy (48-week Treatment) Description: Slow responders (defined as being polymerase chain reaction [PCR] positive at Week 12 with at least 2 log reduction in viral load and PCR negative at Week 24) who are randomized at Week 48 to stop treatment at Week 48.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Standard Therapy\",\n        \"dosage\": \"48-week Treatment\",\n        \"frequency\": \"Slow responders (defined as being polymerase chain reaction [PCR] positive at Week 12 with at least 2 log reduction in viral load and PCR negative at Week 24)\",\n        \"start\": \"Week 48\",\n        \"end\": \"Week 48\"\n    }\n]###"}
{"prompt":"\n    \"Title: Extended Therapy (72-week Treatment) Description: Slow responders (defined as being PCR positive at Week 12 with at least 2 log reduction in viral load and PCR negative at Week 24) who are randomized at Week 48 to continue treatment to Week 72.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Extended Therapy\",\n        \"dosage\": \"2 log reduction in viral load\",\n        \"frequency\": \"Week 12, Week 24, Week 48, Week 72\",\n        \"start\": \"Week 12\",\n        \"end\": \"Week 72\"\n    }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: NAFLD - Niacin Description: subjects given niacin for 16 weeks\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Niacin\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"16 weeks\",\n        \"end\": \"32 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Prazosin Description: Prazosin titrated to 16 mg daily x 6 weeks\n\nPrazosin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Prazosin\",\n        \"dosage\": \"16 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"6 weeks\",\n        \"end\": \"12 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tacrolimus Description: Participants received tacrolimus BID, administered according to standard institutional practice up to 72 months. Tacrolimus dosage was adjusted to achieve pre-determined target predose (trough) tacrolimus levels in whole blood (5-12 ng\/mL through 12 months post-transplant, 3-10 ng\/mL thereafter). In addition, African-American participants may have received MMF, up to 3 gm per day through Month 6 post-transplant. Participants also received corticosteroids (prednisone \u22645 mg daily [or equivalent] through at least 12 months post-transplant. Thereafter, steroids may have been discontinued at the investigator's discretion.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tacrolimus\",\n        \"dosage\": \"BID\",\n        \"frequency\": \"administered according to standard institutional practice\",\n        \"start\": \"up to 72 months\",\n        \"end\": \"72 months post-transplant\"\n    },\n    {\n        \"medication\": \"MMF\",\n        \"dosage\": \"3 gm per day\",\n        \"frequency\": \"daily\",\n        \"start\": \"up to 6 months post-transplant\",\n        \"end\": \"6 months post-transplant\"\n    },\n    {\n        \"medication\": \"Corticosteroids\",\n        \"dosage\": \"prednisone \u22645 mg daily (or equivalent)\",\n        \"frequency\": \"daily\",\n        \"start\": \"up to 12 months post-transplant\",\n        \"end\": \"12 months post-transplant\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tofacitinib 15-10-5 mg BID Description: Participants receiving tofacitinib 15 mg, tablets, PO, BID at study entry (rollover from Parent Study A3921009) reduced the dose of tofacitinib to 10 mg BID on entry into Study A3921021. Within the window of Months 12-24 post-transplant, tofacitinib dosage was then tapered from 10 mg BID to 5 mg BID over 4 weeks (5 mg in the morning and 10 mg in the evening for 4 weeks, then 5 mg BID thereafter) and the participant remained on 5 mg BID throughout the duration of the study, for a maximum of 90 months. In addition, African-American participants may have received MMF, up to 3 gm per day through Month 6 post-transplant. Participants also received corticosteroids (prednisone \u22645 mg daily [or equivalent] through at least 12 months post-transplant. Thereafter, steroids may have been discontinued at the investigator's discretion.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"15 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 12 post-transplant\",\n        \"end\": \"Month 24 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"5 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 24 post-transplant\",\n        \"end\": \"90 months\"\n    },\n    {\n        \"medication\": \"MMF\",\n        \"dosage\": \"3 gm\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 6 post-transplant\"\n    },\n    {\n        \"medication\": \"Corticosteroids\",\n        \"dosage\": \"\u22645 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tofacitinib 30-15-10 mg BID Description: Participants receiving tofacitinib 30 mg, tablets, PO, BID at study entry (rollover from Parent Study A3921009) tapered tofacitinib dosage from 30 mg BID to 15 mg BID over 4 weeks on entry into Study A3921021 (25 mg BID for 2 weeks, 20 mg BID for 2 weeks, then 15 mg BID thereafter). Within the window of Months 12-24 post-transplant, tofacitinib dosage was tapered from 15 mg BID to 10 mg BID and participants remained on 10 mg BID throughout the duration of the study, for a maximum of 90 months. Participants also received corticosteroids (prednisone \u22645 mg daily [or equivalent] through at least 12 months post-transplant. Thereafter, steroids may have been discontinued at the investigator's discretion.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"30 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"15 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 12 post-transplant\",\n        \"end\": \"Month 24 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 24 post-transplant\",\n        \"end\": \"90 months\"\n    },\n    {\n        \"medication\": \"Corticosteroids\",\n        \"dosage\": \"\u22645 mg daily\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tofacitinib 15-10-5 mg BID Description: Participants receiving tofacitinib 15 mg, tablets, PO, BID at study entry (rollover from Parent Study A3921009) reduced the dose of tofacitinib to 10 mg BID on entry into Study A3921021. Within the window of Months 12-24 post-transplant, tofacitinib dosage was then tapered from 10 mg BID to 5 mg BID over 4 weeks (5 mg in the morning and 10 mg in the evening for 4 weeks, then 5 mg BID thereafter) and the participant remained on 5 mg BID throughout the duration of the study, for a maximum of 90 months. In addition, African-American participants may have received MMF, up to 3 gm per day through Month 6 post-transplant. Participants also received corticosteroids (prednisone \u22645 mg daily [or equivalent] through at least 12 months post-transplant. Thereafter, steroids may have been discontinued at the investigator's discretion.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"15 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 12 post-transplant\",\n        \"end\": \"Month 24 post-transplant\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"5 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 24 post-transplant\",\n        \"end\": \"90 months\"\n    },\n    {\n        \"medication\": \"MMF\",\n        \"dosage\": \"3 gm\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 6 post-transplant\"\n    },\n    {\n        \"medication\": \"Corticosteroids\",\n        \"dosage\": \"\u22645 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12 post-transplant\"\n    }\n]###"}
{"prompt":"\n    \"Title: Tofacitinib 30-15-10 mg BID Description: Participants receiving tofacitinib 30 mg, tablets, PO, BID at study entry (rollover from Parent Study A3921009) tapered tofacitinib dosage from 30 mg BID to 15 mg BID over 4 weeks on entry into Study A3921021 (25 mg BID for 2 weeks, 20 mg BID for 2 weeks, then 15 mg BID thereafter). Within the window of Months 12-24 post-transplant, tofacitinib dosage was tapered from 15 mg BID to 10 mg BID and participants remained on 10 mg BID throughout the duration of the study, for a maximum of 90 months. Participants also received corticosteroids (prednisone \u22645 mg daily [or equivalent] through at least 12 months post-transplant. Thereafter, steroids may have been discontinued at the investigator's discretion.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"30 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"15 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 12\",\n        \"end\": \"Month 24\"\n    },\n    {\n        \"medication\": \"Tofacitinib\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"Month 24\",\n        \"end\": \"90 months\"\n    },\n    {\n        \"medication\": \"Prednisone\",\n        \"dosage\": \"\u22645 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"Study entry\",\n        \"end\": \"Month 12\"\n    }\n]###"}
{"prompt":"\n    \"Title: Enteric Coated Mycophenolate-sodium Description: Enteric coated tablets of mycophenolate-sodium taken orally twice a day for 6-8 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Mycophenolate-sodium\",\n        \"dosage\": \"Enteric coated tablets\",\n        \"frequency\": \"twice a day\",\n        \"start\": \"6 weeks\",\n        \"end\": \"8 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib + Erlotinib Description: Erlotinib 150 mg oral tablets once daily (QD) in a continuous regimen expressed in 4-week cycles and Sunitinib 37.5 mg oral capsules QD in a continuous regimen expressed in 4-week cycles.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"once daily (QD)\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"continuous regimen\"\n    },\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"37.5 mg\",\n        \"frequency\": \"once daily (QD)\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"continuous regimen\"\n    }\n]###"}
{"prompt":"\n    \"Title: Erlotinib + Placebo Description: Erlotinib 150 mg oral tablets QD in a continuous regimen expressed in 4-week cycles and Placebo oral capsules QD in a continuous regimen expressed in 4-week cycles.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"4-week cycles\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"oral capsules\",\n        \"frequency\": \"QD\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"4-week cycles\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib + Erlotinib (Amended Lead-In Arm A) Description: Sunitinib 37.5 mg oral capsules QD for 28 days each cycle (27 days in Cycle 1) and Erlotinib 150 mg oral tablets QD for 28 days each cycle (7 days in Cycle 1).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"37.5 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"Cycle 1 Day 1\",\n        \"end\": \"Cycle 1 Day 27\"\n    },\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"Cycle 1 Day 1\",\n        \"end\": \"Cycle 1 Day 28\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib+Erlotinib (Amended Lead-In Arm B) Description: Sunitinib 37.5 mg oral capsules QD for 28 days each cycle (13 days in Cycle 1) and Erlotinib 150 mg oral tablets QD for 28 days each cycle (26 days in Cycle 1)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"37.5 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"Cycle 1, day 1\",\n        \"end\": \"Cycle 1, day 13\"\n    },\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"Cycle 1, day 1\",\n        \"end\": \"Cycle 1, day 26\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sunitinib + Erlotinib (All Combined) Description: Combined Data from all participants in the Original Lead-In Cohort, Amended Lead-In Cohort (Arms A and B), and Randomized Cohort\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"start of trial\",\n        \"end\": \"end of trial\"\n    },\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"start of trial\",\n        \"end\": \"end of trial\"\n    }\n]###"}
{"prompt":"\n    \"Title: All Participants Description: All participants in all phases.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Sunitinib + Erlotinib Description: Erlotinib 150 mg oral tablets QD in a continuous regimen expressed in 4-week cycles and Sunitinib 37.5 mg oral capsules QD in a continuous regimen expressed in 4-week cycles.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Erlotinib\",\n        \"dosage\": \"150 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"4-week cycles\"\n    },\n    {\n        \"medication\": \"Sunitinib\",\n        \"dosage\": \"37.5 mg\",\n        \"frequency\": \"QD\",\n        \"start\": \"4-week cycles\",\n        \"end\": \"4-week cycles\"\n    }\n]###"}
{"prompt":"\n    \"Title: All Participants Description: All participants in all phases\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Valganciclovir Description: 900mg PO qd\n\nValganciclovir : 900mg PO qd x 8 weeks followed by 4 weeks of observation on background ARV regimen alone.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Valganciclovir\",\n        \"dosage\": \"900mg\",\n        \"frequency\": \"PO qd\",\n        \"start\": \"now\",\n        \"end\": \"8 weeks\"\n    },\n    {\n        \"medication\": \"Valganciclovir\",\n        \"dosage\": \"900mg\",\n        \"frequency\": \"PO qd\",\n        \"start\": \"8 weeks\",\n        \"end\": \"12 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Valganciclovir Description: 900mg PO qd\n\nValganciclovir: 900mg PO qd x 8 weeks followed by 4 weeks of observation on background antiretroviral (ARV) regimen alone.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Valganciclovir\",\n        \"dosage\": \"900mg\",\n        \"frequency\": \"PO qd\",\n        \"start\": \"now\",\n        \"end\": \"8 weeks\"\n    },\n    {\n        \"medication\": \"ARV regimen\",\n        \"dosage\": \"NA\",\n        \"frequency\": \"NA\",\n        \"start\": \"8 weeks\",\n        \"end\": \"12 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: 900mg PO qd\n\nPlacebo: Placebo designed to resemble Valganciclovir\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"900mg\",\n        \"frequency\": \"PO qd\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Placebo X 6 weeks\n\nPlacebo\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1\",\n        \"frequency\": \u201cN\/A\u201d,\n        \"start\": \"now\",\n        \"end\": \"6 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Pemetrexed\/Carboplatin Description: Pemetrexed+Carboplatin+Radiation carboplatin: carboplatin is to be given on days 1 and 22 of the 5 \u00bd weeks of radiation treatment.\n\nPemetrexed: Pemetrexed is to be given on days 1 and 22 of the 5 \u00bd weeks of radiation treatment.\n\nRadiation therapy: Radiation therapy begins day 1 and continues for 5 \u00bd weeks (45 Gy in 22-25 fractions of 1.8 Gy to extended field; 50.4 Gy in 28 fractions within boost field).\n\nconventional surgery\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Pemetrexed\",\n            \"dosage\": \"unknown\",\n            \"frequency\": \"2 times per 5 \u00bd weeks\",\n            \"start\": \"day 1\",\n            \"end\": \"day 22\"\n        },\n        {\n            \"medication\": \"Carboplatin\",\n            \"dosage\": \"unknown\",\n            \"frequency\": \"2 times per 5 \u00bd weeks\",\n            \"start\": \"day 1\",\n            \"end\": \"day 22\"\n        },\n        {\n            \"medication\": \"Radiation therapy\",\n            \"dosage\": \"45 Gy in 22-25 fractions of 1.8 Gy to extended field; 50.4 Gy in 28 fractions within boost field\",\n            \"frequency\": \"daily\",\n            \"start\": \"day 1\",\n            \"end\": \"5 \u00bd weeks\"\n        },\n        {\n            \"medication\": \"Conventional surgery\",\n            \"dosage\": \"unknown\",\n            \"frequency\": \"unknown\",\n            \"start\": \"unknown\",\n            \"end\": \"unknown\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Pemetrexed\/Carboplatin Description: Pemetrexed+Carboplatin+Radiation carboplatin: carboplatin is to be given on days 1 and 22 of the 5 \u00bd weeks of radiation treatment.\n\nPemetrexed: Pemetrexed is to be given on days 1 and 22 of the 5 \u00bd weeks of radiation treatment.\n\nRadiation therapy: Radiation therapy begins day 1 and continues for 5 \u00bd weeks (45 Gy in 22-25 fractions of 1.8 Gy to extended field; 50.4 Gy in 28 fractions within boost field).\n\nConventional surgery\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Pemetrexed\",\n        \"dosage\": \"500mg\/m2\",\n        \"frequency\": \"twice\",\n        \"start\": \"day 1\",\n        \"end\": \"day 22\"\n    },\n    {\n        \"medication\": \"Carboplatin\",\n        \"dosage\": \"AUC 5-7\",\n        \"frequency\": \"twice\",\n        \"start\": \"day 1\",\n        \"end\": \"day 22\"\n    },\n    {\n        \"medication\": \"Radiation therapy\",\n        \"dosage\": \"45 Gy in 22-25 fractions of 1.8 Gy to extended field; 50.4 Gy in 28 fractions within boost field\",\n        \"frequency\": \"daily\",\n        \"start\": \"day 1\",\n        \"end\": \"5 \u00bd weeks\"\n    },\n    {\n        \"medication\": \"Conventional surgery\",\n        \"dosage\": \"NA\",\n        \"frequency\": \"once\",\n        \"start\": \"NA\",\n        \"end\": \"NA\"\n    }\n]###"}
{"prompt":"\n    \"Title: 1 g Amethocaine Gel 4% Description: 1 g Amethocaine gel 4% was used as the active drug\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Amethocaine Gel 4%\",\n            \"dosage\": \"1 g\",\n            \"frequency\": \"once\",\n            \"start\": \"now\",\n            \"end\": \"NA\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Amethocaine Gel 4% Group Description: 1 g Amethocaine gel 4% was used as the active drug\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Amethocaine Gel 4%\",\n            \"dosage\": \"1 g\",\n            \"frequency\": \"Once\",\n            \"start\": \"\",\n            \"end\": \"\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: OROS Hydromorphone HCl Description: Initial dose 8 mg (minimum dose), 16 mg, or 32 mg (maximum dose), oral administration, once-daily, 4 weeks (titration phase), 20 weeks (maintenance phase), 28 weeks (extension phase)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"OROS Hydromorphone HCl\",\n        \"dosage\": \"8 mg (minimum dose), 16 mg, or 32 mg (maximum dose)\",\n        \"frequency\": \"once-daily\",\n        \"start\": \"titration phase\",\n        \"end\": \"extension phase\"\n    }\n]###"}
{"prompt":"\n    \"Title: Oxycodone Description: Initial dose 10 mg (minimum dose), 20 mg, and 40 mg, oral administration, twice daily, 4 weeks (titration phase), 20 weeks (maintenance phase), and 28 weeks (extension phase)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Oxycodone\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"4 weeks\",\n        \"end\": \"20 weeks\"\n    },\n    {\n        \"medication\": \"Oxycodone\",\n        \"dosage\": \"20 mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"4 weeks\",\n        \"end\": \"20 weeks\"\n    },\n    {\n        \"medication\": \"Oxycodone\",\n        \"dosage\": \"40 mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"4 weeks\",\n        \"end\": \"28 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 2: Golimumab 100 mg + Placebo Description: Golimumab 100 mg SC injections every 4 weeks from Week 0 for up to 5 years; placebo capsules weekly from Week 0 for up to 5 years (unless early escape at Week 28); Methotrexate - if early escape, 10 to 20 mg weekly from Week 28 up to 5 years; Methotrexate - Dr's discretion after unblinding (in participants receiving golimumab plus placebo) 10 to 20 mg weekly for up to 5 years; Golimumab - Dr's discretion after unblinding, dose adjusted from 100 to 50mg. Duration of the blinded period was until the week-52 database lock.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"100 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 5 years\"\n    },\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"capsules\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 5 years\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"10 to 20 mg\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Week 28\",\n        \"end\": \"Week 5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"dose adjusted\",\n        \"start\": \"Week 52\",\n        \"end\": \"Week 5 years\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 3: Golimumab 50 mg + Methotrexate Description: Golimumab 50 mg SC injections every 4 weeks from Week 0 for up to 5 years (unless early escape at week 28); Methotrexate - 10 to 20 mg weekly from Week 0 for up to 5 years; Golimumab - if early escape, 100 mg SC injections every 4 weeks from Week 28 for up to 5 yrs; Golimumab - Dr's discretion after unblinding, dose adjusted from 50 to 100 mg and from 100 to 50mg. Duration of the blinded period was until the week-52 database lock.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"up to 5 years\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"10 to 20 mg\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Week 0\",\n        \"end\": \"up to 5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"100 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 28\",\n        \"end\": \"up to 5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 to 100 mg or 100 to 50 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 28\",\n        \"end\": \"Dr's discretion after unblinding\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group 4: Golimumab 100 mg + Methotrexate Description: Golimumab 100 mg SC injections every 4 weeks from Week 0 for up to 5 years; Methotrexate - 10 to 20 mg weekly from Week 0 for up to 5 years; Golimumab - Dr's discretion after unblinding, dose adjusted from 100 to 50mg. Duration of the blinded period was until the week-52 database lock.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"100 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Week 0\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"10 to 20 mg\",\n        \"frequency\": \"weekly\",\n        \"start\": \"Week 0\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"Dr's discretion after unblinding\",\n        \"start\": \"Week 0\",\n        \"end\": \"Week 52\"\n    }\n]###"}
{"prompt":"\n    \"Title: Combined Golimumab + Methotrexate Description: Combines Group 3 (golimumab 50 mg + methotrexate) and Group 4 (golimumab 100 mg + methotrexate)\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"Once a week\",\n        \"start\": \"Immediately\",\n        \"end\": \"Indefinitely\"\n    },\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"2.5 mg\",\n        \"frequency\": \"Once a week\",\n        \"start\": \"Immediately\",\n        \"end\": \"Indefinitely\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Plus Day Hospital Description: After a 2-week baseline period, placebo was administered for 10 weeks (weeks 3-12 of the study). Day hospital program involved attendance 4 days a week from 9:00 am to 6:00 pm for 12 to 14 weeks, and supervised meals and group therapy.\n\nDay Hospital: Day hospital program involved attendance 4 days a week from 9:00 am to 6:00 pm for 12 to 14 weeks, and supervised meals and group therapy.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"NA\",\n        \"frequency\": \"10 weeks (weeks 3-12 of the study)\",\n        \"start\": \"NA\",\n        \"end\": \"NA\"\n    },\n    {\n        \"medication\": \"Day Hospital Program\",\n        \"dosage\": \"NA\",\n        \"frequency\": \"4 days a week from 9:00 am to 6:00 pm for 12 to 14 weeks\",\n        \"start\": \"9:00 am\",\n        \"end\": \"6:00 pm\"\n    }\n]###"}
{"prompt":"\n    \"Title: Ziprasidone Description: Dosing was flexible, with dosing adjustments made at the discretion of the investigator to maintain optimal efficacy and tolerability. For subjects having a body weight of 45 kilograms (kg) or greater, the target dosage range was 40-80 milligrams (mg) twice per day (BID) (80-160 mg\/day). For subjects having a body weight under 45 kg, the maximum permitted dose was 80 mg\/day (40 mg BID).\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Ziprasidone\",\n        \"dosage\": \"40-80 mg\",\n        \"frequency\": \"BID\",\n        \"start\": \"\",\n        \"end\": \"\"\n    },\n    {\n        \"medication\": \"Ziprasidone\",\n        \"dosage\": \"80-160 mg\",\n        \"frequency\": \"per day\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Treatment I: Placebo orally once daily\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1\",\n        \"frequency\": \"once daily\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\u201d\n    }\n]###"}
{"prompt":"\n    \"Title: Etoricoxib 10 mg Description: Treatment I: Etoricoxib 10 mg orally once daily\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[{\n        \"medication\": \"Etoricoxib\",\n        \"dosage\": \"10 mg\",\n        \"frequency\": \"once daily\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }]###"}
{"prompt":"\n    \"Title: Day 8 Description: Day 8 pre-dose\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Plavix and Aspirin Description: Patients will receive a 300 mg loading dose of Plavix on day 1, followed by 75 mg\/day, and aspirin 81 mg per day starting day 1. Treatment will be continued until the treating physician elects to resume systemic therapy for the treatment of breast cancer or until unacceptable toxicity is observed. A pill diary will be collected monthly to monitor patients' compliance with the medication regimen.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Plavix\",\n        \"dosage\": \"300 mg\",\n        \"frequency\": \"once\",\n        \"start\": \"day 1\",\n        \"end\": \"until unacceptable toxicity is observed\"\n    },\n    {\n        \"medication\": \"Aspirin\",\n        \"dosage\": \"81 mg\",\n        \"frequency\": \"daily\",\n        \"start\": \"day 1\",\n        \"end\": \"until unacceptable toxicity is observed\"\n    }\n]###"}
{"prompt":"\n    \"Title: Observation Only Description: Observation by treating physician\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Plavix\",\n        \"dosage\": \u201cN\/A\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\"\n    },\n    {\n        \"medication\": \"Aspirin\",\n        \"dosage\": \u201cN\/A\",\n        \"frequency\": \u201cN\/A\",\n        \"start\": \u201cN\/A\",\n        \"end\": \u201cN\/A\u201d\n    }\n]###"}
{"prompt":"\n    \"nan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Plavix and Aspirin Description: Patients will receive a 300 mg loading dose of Plavix on day 1, followed by 75 mg\/day, and aspirin 81 mg per day starting day 1. Treatment will be continued until the treating physician elects to resume systemic therapy for the treatment of breast cancer or until unacceptable toxicity is observed. A pill diary will be collected monthly to monitor patients' compliance with the medication regimen.\n\nPlavix\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Plavix\",\n        \"dosage\": \"300 mg\",\n        \"frequency\": \"once a day\",\n        \"start\": \"day 1\",\n        \"end\": \"until unacceptable toxicity is observed\"\n    },\n    {\n        \"medication\": \"Aspirin\",\n        \"dosage\": \"81 mg\",\n        \"frequency\": \"once a day\",\n        \"start\": \"day 1\",\n        \"end\": \"until unacceptable toxicity is observed\"\n    }\n]###"}
{"prompt":"\n    \"Title: RT + Cisplatin Description: Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"\n[\n    {\n        \"medication\": \"Radiation therapy\",\n        \"dosage\": \"Accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT)\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Immediately\",\n        \"end\": \"Until completion\"\n    },\n    {\n        \"medication\": \"Cisplatin\",\n        \"dosage\": \"As prescribed\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Immediately\",\n        \"end\": \"Until completion\"\n    }\n]###"}
{"prompt":"\n    \"Title: RT + Cisplatin + Cetuximab Description: Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin plus cetuximab\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"    \n    [\n        {\n            \"medication\": \"Radiation Therapy\",\n            \"dosage\": \"Accelerated Fractionation by Concomitant Boost (AFX-CB) or Intensity-Modulated Radiation Therapy (IMRT)\",\n            \"frequency\": \"Daily\",\n            \"start\": \"TBD\",\n            \"end\": \"TBD\"\n        },\n        {\n            \"medication\": \"Cisplatin\",\n            \"dosage\": \"TBD\",\n            \"frequency\": \"TBD\",\n            \"start\": \"TBD\",\n            \"end\": \"TBD\"\n        },\n        {\n            \"medication\": \"Cetuximab\",\n            \"dosage\": \"TBD\",\n            \"frequency\": \"TBD\",\n            \"start\": \"TBD\",\n            \"end\": \"TBD\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Low EGFR Description: Less than 80% EGFR\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: High EGFR Description: Greater than or equal to 80% EGFR\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Low PET SUVmax Description: Less than or equal to median pretreatment PET SUVmax\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: High PET SUVmax Description: Greater than median pretreatment PET SUVmax\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Clinical CR + Negative PET Description: Clinical nodal complete response; negative post-treatment PET\/CT scan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: No Clinical CR + Negative PET Description: Did not have clinical nodal complete response; negative post-treatment PET\/CT scan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Clinical CR + Positive PET Description: Clinical nodal complete response; positive post-treatment PET\/CT scan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: No Clinical CR + Positive PET Description: No clinical nodal complete response; positive post-treatment PET\/CT scan\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \u201cN\/A\u201c,\n            \"dosage\": \"N\/A\",\n            \"frequency\": \"N\/A\",\n            \"start\": \"N\/A\",\n            \"end\": \u201cN\/A\"\n        }\n]###"}
{"prompt":"\n    \"Title: Intervention Description: Argatroban IV Infusion 1 mcg\/kg\/min for 48 hours\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Argatroban\",\n            \"dosage\": \"1 mcg\/kg\/min\",\n            \"frequency\": \"IV Infusion\",\n            \"start\": \"now\",\n            \"end\": \"48 hours\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Edaravone Group Description: Edaravone Group\n\nedaravone: intravenous administration of 30mg Edaravone just before reperfusion therapy\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Edaravone\",\n        \"dosage\": \"30mg\",\n        \"frequency\": \"once\",\n        \"start\": \"just before reperfusion therapy\",\n        \"end\": \"NA\"\n    }\n]###"}
{"prompt":"\n    \"Title: Single ARM Study Description: It was a single arm study with daptomycin use at a higher dose for patients with severe skin and soft tissue infections.\n\nDaptomycin 6mg\/kg\/day\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Daptomycin\",\n        \"dosage\": \"6mg\/kg\/day\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Immediately\",\n        \"end\": \"Until completion of treatment\"\n    }\n]###"}
{"prompt":"\n    \"Title: Responders: Memantine Open Label Description: Participants who respond to memantine as adjunctive therapy defined as Y-BOCS decrease of greater than or equal to 25% from baseline and a CGI-I rating of \"much\" or \"very much\" improved.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Memantine\",\n            \"dosage\": \"20mg\",\n            \"frequency\": \"Once daily\",\n            \"start\": \"Day 1\",\n            \"end\": \"Ongoing\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Group I: Placebo Description: Placebo subcutaneous (SC) injections every 4 weeks from week (Wk) 0 through Wk 20 (unless early escape at Wk 16); golimumab - if early escape, 50 mg SC injection from Wk 16 up to 5 years (yrs); golimumab - 50 mg SC injection beginning Wk 24 up to 5 yrs (unless early escape); golimumab - Doctor's (Dr's) discretion after unblinding (last patient completes the Wk 52 evaluation and database is locked), dose adjust from 50 to 100 mg.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"placebo\",\n        \"dosage\": \"subcutaneous injections\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"week 0\",\n        \"end\": \"week 20\"\n    },\n    {\n        \"medication\": \"golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"week 16\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"golimumab\",\n        \"dosage\": \"50 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"week 24\",\n        \"end\": \"5 years\"\n    },\n    {\n        \"medication\": \"golimumab\",\n        \"dosage\": \"50-100 mg\",\n        \"frequency\": \"doctor's discretion\",\n        \"start\": \"after unblinding\",\n        \"end\": \"database is locked\"\n    }\n]###"}
{"prompt":"\n    \"Title: Group III: Golimumab 100 mg Description: Golimumab 100 mg SC injections every 4 weeks from Wk 0 up to 5 yrs.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Golimumab\",\n        \"dosage\": \"100 mg\",\n        \"frequency\": \"every 4 weeks\",\n        \"start\": \"Wk 0\",\n        \"end\": \"5 yrs\"\n    }\n]###"}
{"prompt":"\n    \"Title: Dabigatran 110 mg Description: 110 mg twice daily, total daily dose 220 mg\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Dabigatran\",\n        \"dosage\": \"110 mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"\",\n        \"end\": \"\"\n    }\n]###"}
{"prompt":"\n    \"Title: Dabigatran 150 mg Description: 150 mg twice daily, total daily dose 300 mg\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n        {\n            \"medication\": \"Dabigatran\",\n            \"dosage\": \"150 mg\",\n            \"frequency\": \"twice daily\",\n            \"start\": \"\",\n            \"end\": \"\"\n        }\n    ]###"}
{"prompt":"\n    \"Title: Warfarin Description: Target International Normalized Ratio (INR) of 2.0 to 3.0\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Warfarin\",\n        \"dosage\": \"2.0 to 3.0\",\n        \"frequency\": \"daily\",\n        \"start\": \"immediately\",\n        \"end\": \"until target INR is achieved\"\n    }\n]###"}
{"prompt":"\n    \"Title: Study Intervention Description: Neo-adjuvant cisplatin, gemcitabine and bevacizumab followed by radical cystectomy. Patients without residual disease will enter follow up after surgery. Patients with residual disease will receive adjuvant therapy with bevacizumab and ciaplatin.\n\nbevacizumab: Before surgery: given as a 15mg\/kg IV over 90 minutes every 21 days for 4 cycles\n\nAfter surgery: given as a 15mg\/kg IV over 90 minutes every 21 days for 3 cycles\n\ncisplatin: Before surgery: given as a 70mg\/m2 IV over 60 minutes every 21 days for 4 cycles\n\ngemcitabine hydrochloride: Before surgery: given as a 1000mg\/m2 IV over 30 minutes on days 1 and 8 of a 21 day cycle for 4 cycles\n\npaclitaxel: After surgery: given as a 175 mg\/m2 dose ver 3 hours every 21 days for 3 cycles\n\ncysectomy\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"bevacizumab\",\n        \"dosage\": \"15mg\/kg\",\n        \"frequency\": \"every 21 days\",\n        \"start\": \"before surgery\",\n        \"end\": \"after surgery\"\n    },\n    {\n        \"medication\": \"cisplatin\",\n        \"dosage\": \"70mg\/m2\",\n        \"frequency\": \"every 21 days\",\n        \"start\": \"before surgery\",\n        \"end\": \"before surgery\"\n    },\n    {\n        \"medication\": \"gemcitabine hydrochloride\",\n        \"dosage\": \"1000mg\/m2\",\n        \"frequency\": \"every 21 days\",\n        \"start\": \"before surgery\",\n        \"end\": \"before surgery\"\n    },\n    {\n        \"medication\": \"paclitaxel\",\n        \"dosage\": \"175 mg\/m2\",\n        \"frequency\": \"every 21 days\",\n        \"start\": \"after surgery\",\n        \"end\": \"after surgery\"\n    },\n    {\n        \"medication\": \"cysectomy\",\n        \"dosage\": \"N\/A\",\n        \"frequency\": \"N\/A\",\n        \"start\": \"N\/A\",\n        \"end\": \"N\/A\"\n    }\n]###"}
{"prompt":"\n    \"Title: Sorafenib Description: Patients receive oral Sorafenib 400mg twice daily on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Sorafenib\",\n        \"dosage\": \"400mg\",\n        \"frequency\": \"twice daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 28\"\n    }\n]###"}
{"prompt":"\n    \"Title: NAFLD - Niacin Description: subjects with elevated levels of intra-hepatic trigleceride given a 16 week course of niacin\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Niacin\",\n        \"dosage\": \"500mg\",\n        \"frequency\": \"2 times a day\",\n        \"start\": \"Week 1\",\n        \"end\": \"Week 16\"\n    }\n]###"}
{"prompt":"\n    \"Title: NAFLD - Fenofibrate Description: Subjects with intrahepatic triglyceride signal greater than 10% per MR spectroscopy receiving fenofibrate for eight weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Fenofibrate\",\n        \"dosage\": \"200mg\",\n        \"frequency\": \"Once daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Week 8\"\n    }\n]###"}
{"prompt":"\n    \"Title: Placebo Description: Placebo, once on Day 1 of Treatment Period 1, 2, 3, or 4.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Placebo\",\n        \"dosage\": \"1\",\n        \"frequency\": \"Once\",\n        \"start\": \"Day 1 of Treatment Period 1\",\n        \"end\": \"Day 1 of Treatment Period 4\"\n    }\n]###"}
{"prompt":"\n    \"Title: Mitoxantrone, Chlorambucil, Prednisolone (MCP) Description: Participants received mitoxantrone 8 mg\/m^2, IV, on Days 1 and 2, chlorambucil 3 x 3 mg\/m^2, PO, every 8 hours on Days 1 through 5, and prednisolone at 25 mg\/m^2, PO on Days 1 through 5. This cycle was repeated at 4-week intervals for a minimum of 6 cycles and a maximum of 8 cycles. After Cycles 2 and 6, participants were assessed for response; participants with no change or with progressive disease (or with minimal response at Cycle 6) were withdrawn from therapy. Participants achieving a CR or PR following induction therapy with MCP were administered maintenance therapy (per standard of care and at the discretion of the investigator) with IFN alpha 3 x 4.5 mIU per week, SC, until progression or withdrawal. Participants could have also received 3 x 500 mg of paracetamol\/day during the first weeks of IFN therapy.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Mitoxantrone\",\n        \"dosage\": \"8 mg\/m^2\",\n        \"frequency\": \"IV, on Days 1 and 2\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 2\"\n    },\n    {\n        \"medication\": \"Chlorambucil\",\n        \"dosage\": \"3 x 3 mg\/m^2\",\n        \"frequency\": \"PO, every 8 hours\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 5\"\n    },\n    {\n        \"medication\": \"Prednisolone\",\n        \"dosage\": \"25 mg\/m^2\",\n        \"frequency\": \"PO\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 5\"\n    },\n    {\n        \"medication\": \"IFN alpha\",\n        \"dosage\": \"3 x 4.5 mIU per week\",\n        \"frequency\": \"SC\",\n        \"start\": \"After Cycles 2 and 6\",\n        \"end\": \"Until progression or withdrawal\"\n    },\n    {\n        \"medication\": \"Paracetamol\",\n        \"dosage\": \"3 x 500 mg\",\n        \"frequency\": \"PO\",\n        \"start\": \"First weeks of IFN therapy\",\n        \"end\": \"First weeks of IFN therapy\"\n    }\n]###"}
{"prompt":"\n    \"Title: Treatment (Chemotherapy, Enzyme Inhibitor Therapy) Description: INDUCTION THERAPY: Patients receive methotrexate IV; vincristine IV and asparaginase IM; oral dexamethasone; and alemtuzumab SC on days 1, 4, and 7.\n\nCONSOLIDATION THERAPY: Patients receive methotrexate IV and asparaginase IM.\n\nCYTOREDUCTION THERAPY: Patients receive vincristine IV and oral methotrexate IV; leucovorin calcium IV; and oral dexamethasone.\n\nMAINTENANCE THERAPY: Patients receive oral mercaptopurine; oral methotrexate; vincristine IV; and oral dexamethasone.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Methotrexate\",\n        \"dosage\": \"IV\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Day 1\",\n        \"end\": \"Consolidation Therapy\"\n    },\n    {\n        \"medication\": \"Vincristine\",\n        \"dosage\": \"IV\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Day 1\",\n        \"end\": \"Cytoreduction Therapy\"\n    },\n    {\n        \"medication\": \"Asparaginase\",\n        \"dosage\": \"IM\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Day 1\",\n        \"end\": \"Consolidation Therapy\"\n    },\n    {\n        \"medication\": \"Dexamethasone\",\n        \"dosage\": \"Oral\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Day 1\",\n        \"end\": \"Maintenance Therapy\"\n    },\n    {\n        \"medication\": \"Alemtuzumab\",\n        \"dosage\": \"SC\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 7\"\n    },\n    {\n        \"medication\": \"Leucovorin Calcium\",\n        \"dosage\": \"IV\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Cytoreduction Therapy\",\n        \"end\": \"Cytoreduction Therapy\"\n    },\n    {\n        \"medication\": \"Mercaptopurine\",\n        \"dosage\": \"Oral\",\n        \"frequency\": \"once per day\",\n        \"start\": \"Maintenance Therapy\",\n        \"end\": \"Maintenance Therapy\"\n    }\n]###"}
{"prompt":"\n    \"Title: Bortezomib, Gemcitabine Hydrochloride Description: bortezomib\n\ngemcitabine hydrochloride\n\nBortezomib was administered at a dose of 1 mg\/m2 on days 1, 4, 8,and 11 of a 21-day schedule. Gemcitabine was administered at a dose of 800 mg\/m2 on days 1 and 8 of the same 21-day schedule.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"Bortezomib\",\n        \"dosage\": \"1 mg\/m2\",\n        \"frequency\": \"days 1, 4, 8, and 11\",\n        \"start\": \"21-day schedule\",\n        \"end\": \"21-day schedule\"\n    },\n    {\n        \"medication\": \"Gemcitabine Hydrochloride\",\n        \"dosage\": \"800 mg\/m2\",\n        \"frequency\": \"days 1 and 8\",\n        \"start\": \"21-day schedule\",\n        \"end\": \"21-day schedule\"\n    }\n]###"}
{"prompt":"\n    \"Title: Standard 24+4 Treatment of EE20\/DRSP (YAZ, BAY86-5300) Description: 13 cycles of treatment, each cycle comprising an intake of one tablet daily with 24 days of active tablets (20\u00b5g ethinyl estradiol as betadex clathrate plus 3 mg drospirenone) followed by 4 days of placebo tablets, 13 withdrawal bleeding episodes during one year of treatment were expected.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"YAZ\",\n        \"dosage\": \"1 tablet\",\n        \"frequency\": \"daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 365\"\n    },\n    {\n        \"medication\": \"BAY86-5300\",\n        \"dosage\": \"20\u00b5g ethinyl estradiol as betadex clathrate plus 3 mg drospirenone\",\n        \"frequency\": \"daily\",\n        \"start\": \"Day 1\",\n        \"end\": \"Day 365\"\n    }\n]###"}
{"prompt":"\n    \"Title: OAT + Omalizumab Description: During the 8-week Run-in phase, asthma therapy was evaluated and optimized according to Global Initiative for Asthma (GINA) guidelines. During the treatment phase, participants continued to receive optimized asthma therapy (OAT), plus omalizumab add on therapy for 32 weeks, administered by subcutaneous injection once every 4 weeks. The dosage received was individualized based on body weight and serum IgE level.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"OAT\",\n        \"dosage\": \"optimized asthma therapy\",\n        \"frequency\": \"once every 8 weeks\",\n        \"start\": \"Run-in phase\",\n        \"end\": \"treatment phase\"\n    },\n    {\n        \"medication\": \"Omalizumab\",\n        \"dosage\": \"individualized based on body weight and serum IgE level\",\n        \"frequency\": \"once every 4 weeks\",\n        \"start\": \"treatment phase\",\n        \"end\": \"32 weeks\"\n    }\n]###"}
{"prompt":"\n    \"Title: Optimized Asthma Treatment (OAT) Description: During the 8-week Run-in phase, asthma therapy was evaluated and optimized according to Global Initiative for Asthma (GINA) guidelines. In the treatment phase, participants continued to receive optimized asthma therapy (OAT) established during the run-in period of the study for an additional 32 weeks.\"\n    \n    Please respond in a JSON list where each element of the list is a dictionary of the form\n    \n    ```\n    {\n        \"medication\": \"medication name\",\n        \"dosage\": \"dosage amount\",\n        \"frequency\": \"frequency of dosage\",\n        \"start\": \"start time\",\n        \"end\": \"end time\"\n    }\n    ```\n","completion":"[\n    {\n        \"medication\": \"OAT\",\n        \"dosage\": \"Varies\",\n        \"frequency\": \"Varies\",\n        \"start\": \"8 weeks\",\n        \"end\": \"32 weeks\"\n    }\n]###"}
